id	sid	tid	token	lemma	pos
iajs-2138	1	1	54	54	NUM
iajs-2138	1	2	ibn	ibn	PROPN
iajs-2138	1	3	al	al	PROPN
iajs-2138	1	4	-	-	PUNCT
iajs-2138	1	5	haitham	haitham	PROPN
iajs-2138	1	6	jour	jour	X
iajs-2138	1	7	.	.	PROPN
iajs-2138	1	8	for	for	ADP
iajs-2138	1	9	pure	pure	ADJ
iajs-2138	1	10	&	&	CCONJ
iajs-2138	1	11	appl	appl	PROPN
iajs-2138	1	12	.	.	PUNCT
iajs-2138	2	1	sci	sci	PROPN
iajs-2138	2	2	.	.	PROPN
iajs-2138	2	3	32	32	NUM
iajs-2138	2	4	(	(	PUNCT
iajs-2138	2	5	2	2	NUM
iajs-2138	2	6	)	)	PUNCT
iajs-2138	2	7	2019	2019	NUM
iajs-2138	2	8	abstract	abstract	ADJ
iajs-2138	2	9	study	study	NOUN
iajs-2138	2	10	aimed	aim	VERB
iajs-2138	2	11	to	to	ADP
iajs-2138	2	12	determination	determination	NOUN
iajs-2138	2	13	of	of	ADP
iajs-2138	2	14	chitotriosidase-1	chitotriosidase-1	NOUN
iajs-2138	2	15	levels	level	NOUN
iajs-2138	2	16	in	in	ADP
iajs-2138	2	17	iraqi	iraqi	ADJ
iajs-2138	2	18	diabetic	diabetic	ADJ
iajs-2138	2	19	and	and	CCONJ
iajs-2138	2	20	diabetic	diabetic	ADJ
iajs-2138	2	21	patients	patient	NOUN
iajs-2138	2	22	with	with	ADP
iajs-2138	2	23	thyroid	thyroid	NOUN
iajs-2138	2	24	disorder	disorder	NOUN
iajs-2138	2	25	.	.	PUNCT
iajs-2138	3	1	also	also	ADV
iajs-2138	3	2	,	,	PUNCT
iajs-2138	3	3	study	study	NOUN
iajs-2138	3	4	aimed	aim	VERB
iajs-2138	3	5	to	to	PART
iajs-2138	3	6	found	find	VERB
iajs-2138	3	7	relation	relation	NOUN
iajs-2138	3	8	correlation	correlation	NOUN
iajs-2138	3	9	for	for	ADP
iajs-2138	3	10	chitotriosidase-1	chitotriosidase-1	PROPN
iajs-2138	3	11	with	with	ADP
iajs-2138	3	12	fsg	fsg	PROPN
iajs-2138	3	13	,	,	PUNCT
iajs-2138	3	14	t3	t3	PROPN
iajs-2138	3	15	,	,	PUNCT
iajs-2138	3	16	t4	t4	PROPN
iajs-2138	3	17	and	and	CCONJ
iajs-2138	3	18	tsh	tsh	PROPN
iajs-2138	3	19	.	.	NOUN
iajs-2138	4	1	ninety	ninety	NUM
iajs-2138	4	2	subjects	subject	NOUN
iajs-2138	4	3	were	be	AUX
iajs-2138	4	4	including	include	VERB
iajs-2138	4	5	in	in	ADP
iajs-2138	4	6	this	this	DET
iajs-2138	4	7	study	study	NOUN
iajs-2138	4	8	,	,	PUNCT
iajs-2138	4	9	first	first	ADJ
iajs-2138	4	10	group	group	NOUN
iajs-2138	4	11	consisted	consist	VERB
iajs-2138	4	12	of	of	ADP
iajs-2138	4	13	(	(	PUNCT
iajs-2138	4	14	30	30	NUM
iajs-2138	4	15	)	)	PUNCT
iajs-2138	4	16	healthy	healthy	ADJ
iajs-2138	4	17	individuals	individual	NOUN
iajs-2138	4	18	who	who	PRON
iajs-2138	4	19	have	have	VERB
iajs-2138	4	20	no	no	DET
iajs-2138	4	21	history	history	NOUN
iajs-2138	4	22	of	of	ADP
iajs-2138	4	23	any	any	DET
iajs-2138	4	24	thyroid	thyroid	NOUN
iajs-2138	4	25	disorders	disorder	NOUN
iajs-2138	4	26	or	or	CCONJ
iajs-2138	4	27	diabetes	diabetes	NOUN
iajs-2138	4	28	mellitus	mellitus	NOUN
iajs-2138	4	29	as	as	ADP
iajs-2138	4	30	control	control	NOUN
iajs-2138	4	31	group	group	NOUN
iajs-2138	4	32	.	.	PUNCT
iajs-2138	5	1	second	second	ADJ
iajs-2138	5	2	group	group	NOUN
iajs-2138	5	3	(	(	PUNCT
iajs-2138	5	4	g2	g2	PROPN
iajs-2138	5	5	)	)	PUNCT
iajs-2138	5	6	(	(	PUNCT
iajs-2138	5	7	n=30	n=30	NOUN
iajs-2138	5	8	)	)	PUNCT
iajs-2138	5	9	patients	patient	NOUN
iajs-2138	5	10	with	with	ADP
iajs-2138	5	11	diabetic	diabetic	NOUN
iajs-2138	5	12	and	and	CCONJ
iajs-2138	5	13	hyperthyroidism	hyperthyroidism	NOUN
iajs-2138	5	14	as	as	ADP
iajs-2138	5	15	association	association	NOUN
iajs-2138	5	16	disease	disease	NOUN
iajs-2138	5	17	,	,	PUNCT
iajs-2138	5	18	and	and	CCONJ
iajs-2138	5	19	third	third	ADJ
iajs-2138	5	20	group	group	NOUN
iajs-2138	5	21	(	(	PUNCT
iajs-2138	5	22	g3	g3	PROPN
iajs-2138	5	23	)	)	PUNCT
iajs-2138	5	24	(	(	PUNCT
iajs-2138	5	25	n=30	n=30	CCONJ
iajs-2138	5	26	)	)	PUNCT
iajs-2138	5	27	include	include	VERB
iajs-2138	5	28	patients	patient	NOUN
iajs-2138	5	29	with	with	ADP
iajs-2138	5	30	diabetic	diabetic	ADJ
iajs-2138	5	31	and	and	CCONJ
iajs-2138	5	32	hypothyroidism	hypothyroidism	NOUN
iajs-2138	5	33	as	as	ADP
iajs-2138	5	34	association	association	NOUN
iajs-2138	5	35	disease	disease	NOUN
iajs-2138	5	36	.	.	PUNCT
iajs-2138	6	1	serum	serum	PROPN
iajs-2138	6	2	used	use	VERB
iajs-2138	6	3	in	in	ADP
iajs-2138	6	4	(	(	PUNCT
iajs-2138	6	5	fsg	fsg	PROPN
iajs-2138	6	6	,	,	PUNCT
iajs-2138	6	7	t3	t3	PROPN
iajs-2138	6	8	,	,	PUNCT
iajs-2138	6	9	t4	t4	PROPN
iajs-2138	6	10	,	,	PUNCT
iajs-2138	6	11	tsh	tsh	NOUN
iajs-2138	6	12	,	,	PUNCT
iajs-2138	6	13	and	and	CCONJ
iajs-2138	6	14	chitotriosidase-1	chitotriosidase-1	NOUN
iajs-2138	6	15	)	)	PUNCT
iajs-2138	6	16	determination	determination	NOUN
iajs-2138	6	17	.	.	PUNCT
iajs-2138	7	1	results	result	NOUN
iajs-2138	7	2	showed	show	VERB
iajs-2138	7	3	a	a	DET
iajs-2138	7	4	significant	significant	ADJ
iajs-2138	7	5	elevation	elevation	NOUN
iajs-2138	7	6	in	in	ADP
iajs-2138	7	7	patients	patient	NOUN
iajs-2138	7	8	’	'	PUNCT
iajs-2138	7	9	groups	group	NOUN
iajs-2138	7	10	(	(	PUNCT
iajs-2138	7	11	g2	g2	PROPN
iajs-2138	7	12	,	,	PUNCT
iajs-2138	7	13	g3	g3	PROPN
iajs-2138	7	14	)	)	PUNCT
iajs-2138	7	15	comparing	compare	VERB
iajs-2138	7	16	to	to	AUX
iajs-2138	7	17	control	control	NOUN
iajs-2138	7	18	group	group	NOUN
iajs-2138	7	19	in	in	ADP
iajs-2138	7	20	fsg	fsg	PROPN
iajs-2138	7	21	.	.	PUNCT
iajs-2138	8	1	in	in	ADP
iajs-2138	8	2	addition	addition	NOUN
iajs-2138	8	3	to	to	ADP
iajs-2138	8	4	a	a	DET
iajs-2138	8	5	significant	significant	ADJ
iajs-2138	8	6	elevation	elevation	NOUN
iajs-2138	8	7	in	in	ADP
iajs-2138	8	8	g3	g3	PROPN
iajs-2138	8	9	compared	compare	VERB
iajs-2138	8	10	to	to	ADP
iajs-2138	8	11	g2	g2	PROPN
iajs-2138	8	12	.	.	PUNCT
iajs-2138	9	1	results	result	NOUN
iajs-2138	9	2	,	,	PUNCT
iajs-2138	9	3	also	also	ADV
iajs-2138	9	4	,	,	PUNCT
iajs-2138	9	5	revealed	reveal	VERB
iajs-2138	9	6	a	a	DET
iajs-2138	9	7	significant	significant	ADJ
iajs-2138	9	8	elevation	elevation	NOUN
iajs-2138	9	9	in	in	ADP
iajs-2138	9	10	t3	t3	PROPN
iajs-2138	9	11	and	and	CCONJ
iajs-2138	9	12	t4	t4	PROPN
iajs-2138	9	13	levels	level	NOUN
iajs-2138	9	14	in	in	ADP
iajs-2138	9	15	g2	g2	PROPN
iajs-2138	9	16	when	when	SCONJ
iajs-2138	9	17	comparing	compare	VERB
iajs-2138	9	18	with	with	ADP
iajs-2138	9	19	g1	g1	NOUN
iajs-2138	9	20	and	and	CCONJ
iajs-2138	9	21	g3	g3	NOUN
iajs-2138	9	22	.	.	PUNCT
iajs-2138	10	1	while	while	SCONJ
iajs-2138	10	2	there	there	PRON
iajs-2138	10	3	is	be	VERB
iajs-2138	10	4	significant	significant	ADJ
iajs-2138	10	5	decrease	decrease	NOUN
iajs-2138	10	6	in	in	ADP
iajs-2138	10	7	these	these	DET
iajs-2138	10	8	parameters	parameter	NOUN
iajs-2138	10	9	in	in	ADP
iajs-2138	10	10	g3	g3	PROPN
iajs-2138	10	11	compared	compare	VERB
iajs-2138	10	12	to	to	ADP
iajs-2138	10	13	g1	g1	PROPN
iajs-2138	10	14	and	and	CCONJ
iajs-2138	10	15	g2	g2	PROPN
iajs-2138	10	16	.	.	PUNCT
iajs-2138	11	1	results	result	NOUN
iajs-2138	11	2	revealed	reveal	VERB
iajs-2138	11	3	a	a	DET
iajs-2138	11	4	significant	significant	ADJ
iajs-2138	11	5	decrease	decrease	NOUN
iajs-2138	11	6	in	in	ADP
iajs-2138	11	7	g2	g2	PROPN
iajs-2138	11	8	in	in	ADP
iajs-2138	11	9	tsh	tsh	NOUN
iajs-2138	11	10	levels	level	NOUN
iajs-2138	11	11	comparing	compare	VERB
iajs-2138	11	12	to	to	ADP
iajs-2138	11	13	g1and	g1and	PROPN
iajs-2138	11	14	g3	g3	PROPN
iajs-2138	11	15	.	.	PUNCT
iajs-2138	12	1	while	while	SCONJ
iajs-2138	12	2	there	there	PRON
iajs-2138	12	3	is	be	VERB
iajs-2138	12	4	significant	significant	ADJ
iajs-2138	12	5	increase	increase	NOUN
iajs-2138	12	6	in	in	ADP
iajs-2138	12	7	tsh	tsh	ADJ
iajs-2138	12	8	level	level	NOUN
iajs-2138	12	9	in	in	ADP
iajs-2138	12	10	g3	g3	NOUN
iajs-2138	12	11	compared	compare	VERB
iajs-2138	12	12	to	to	ADP
iajs-2138	12	13	g1	g1	PROPN
iajs-2138	12	14	and	and	CCONJ
iajs-2138	12	15	g2	g2	PROPN
iajs-2138	12	16	.	.	PUNCT
iajs-2138	13	1	results	result	NOUN
iajs-2138	13	2	revealed	reveal	VERB
iajs-2138	13	3	a	a	DET
iajs-2138	13	4	significant	significant	ADJ
iajs-2138	13	5	increase	increase	NOUN
iajs-2138	13	6	in	in	ADP
iajs-2138	13	7	chitotriosidase-1	chitotriosidase-1	PROPN
iajs-2138	13	8	levels	level	NOUN
iajs-2138	13	9	in	in	ADP
iajs-2138	13	10	g2	g2	PROPN
iajs-2138	13	11	comparing	compare	VERB
iajs-2138	13	12	to	to	ADP
iajs-2138	13	13	g1and	g1and	PROPN
iajs-2138	13	14	g3	g3	PROPN
iajs-2138	13	15	.	.	PUNCT
iajs-2138	13	16	results	result	NOUN
iajs-2138	13	17	,	,	PUNCT
iajs-2138	13	18	also	also	ADV
iajs-2138	13	19	,	,	PUNCT
iajs-2138	13	20	showed	show	VERB
iajs-2138	13	21	a	a	DET
iajs-2138	13	22	significant	significant	ADJ
iajs-2138	13	23	decrease	decrease	NOUN
iajs-2138	13	24	in	in	ADP
iajs-2138	13	25	g3	g3	NOUN
iajs-2138	13	26	comparing	compare	VERB
iajs-2138	13	27	to	to	ADP
iajs-2138	13	28	g2	g2	PROPN
iajs-2138	13	29	and	and	CCONJ
iajs-2138	13	30	a	a	DET
iajs-2138	13	31	significant	significant	ADJ
iajs-2138	13	32	increase	increase	NOUN
iajs-2138	13	33	was	be	AUX
iajs-2138	13	34	found	find	VERB
iajs-2138	13	35	in	in	ADP
iajs-2138	13	36	g3	g3	NOUN
iajs-2138	13	37	comparing	compare	VERB
iajs-2138	13	38	to	to	AUX
iajs-2138	13	39	g1	g1	PROPN
iajs-2138	13	40	.	.	PUNCT
iajs-2138	14	1	conclusion	conclusion	NOUN
iajs-2138	14	2	could	could	AUX
iajs-2138	14	3	be	be	AUX
iajs-2138	14	4	drowning	drown	VERB
iajs-2138	14	5	from	from	ADP
iajs-2138	14	6	this	this	DET
iajs-2138	14	7	study	study	NOUN
iajs-2138	14	8	that	that	SCONJ
iajs-2138	14	9	chitotriosidase-1	chitotriosidase-1	PROPN
iajs-2138	14	10	may	may	AUX
iajs-2138	14	11	be	be	AUX
iajs-2138	14	12	helpful	helpful	ADJ
iajs-2138	14	13	in	in	ADP
iajs-2138	14	14	monitoring	monitoring	NOUN
iajs-2138	14	15	and	and	CCONJ
iajs-2138	14	16	early	early	ADJ
iajs-2138	14	17	diagnosis	diagnosis	NOUN
iajs-2138	14	18	of	of	ADP
iajs-2138	14	19	thyroid	thyroid	NOUN
iajs-2138	14	20	disorder	disorder	NOUN
iajs-2138	14	21	in	in	ADP
iajs-2138	14	22	these	these	DET
iajs-2138	14	23	patients	patient	NOUN
iajs-2138	14	24	.	.	PUNCT
iajs-2138	15	1	keywords	keyword	NOUN
iajs-2138	15	2	:	:	PUNCT
iajs-2138	15	3	chitotriosidase-1	chitotriosidase-1	NUM
iajs-2138	15	4	,	,	PUNCT
iajs-2138	15	5	iraqi	iraqi	ADJ
iajs-2138	15	6	diabetic	diabetic	ADJ
iajs-2138	15	7	mellitus	mellitus	NOUN
iajs-2138	15	8	with	with	ADP
iajs-2138	15	9	thyroid	thyroid	NOUN
iajs-2138	15	10	disorder	disorder	NOUN
iajs-2138	15	11	.	.	PUNCT
iajs-2138	16	1	1	1	X
iajs-2138	16	2	.	.	X
iajs-2138	16	3	introduction	introduction	NOUN
iajs-2138	16	4	diabetes	diabetes	NOUN
iajs-2138	16	5	mellitus	mellitus	NOUN
iajs-2138	16	6	(	(	PUNCT
iajs-2138	16	7	dm	dm	PROPN
iajs-2138	16	8	)	)	PUNCT
iajs-2138	16	9	and	and	CCONJ
iajs-2138	16	10	thyroid	thyroid	VERB
iajs-2138	16	11	dysfunction	dysfunction	NOUN
iajs-2138	16	12	are	be	AUX
iajs-2138	16	13	two	two	NUM
iajs-2138	16	14	endocrine	endocrine	NOUN
iajs-2138	16	15	disorders	disorder	NOUN
iajs-2138	16	16	affect	affect	VERB
iajs-2138	16	17	each	each	DET
iajs-2138	16	18	other	other	ADJ
iajs-2138	16	19	in	in	ADP
iajs-2138	16	20	a	a	DET
iajs-2138	16	21	variety	variety	NOUN
iajs-2138	16	22	of	of	ADP
iajs-2138	16	23	ways	way	NOUN
iajs-2138	16	24	.	.	PUNCT
iajs-2138	17	1	thyroid	thyroid	NOUN
iajs-2138	17	2	hormones	hormone	NOUN
iajs-2138	17	3	contribute	contribute	VERB
iajs-2138	17	4	to	to	ADP
iajs-2138	17	5	the	the	DET
iajs-2138	17	6	regulation	regulation	NOUN
iajs-2138	17	7	of	of	ADP
iajs-2138	17	8	carbohydrate	carbohydrate	ADJ
iajs-2138	17	9	metabolism	metabolism	NOUN
iajs-2138	17	10	and	and	CCONJ
iajs-2138	17	11	pancreatic	pancreatic	ADJ
iajs-2138	17	12	function	function	NOUN
iajs-2138	17	13	[	[	X
iajs-2138	17	14	1	1	NUM
iajs-2138	17	15	,	,	PUNCT
iajs-2138	17	16	2	2	NUM
iajs-2138	17	17	]	]	PUNCT
iajs-2138	17	18	.	.	PUNCT
iajs-2138	18	1	reasonable	reasonable	ADJ
iajs-2138	18	2	mechanism	mechanism	NOUN
iajs-2138	18	3	for	for	ADP
iajs-2138	18	4	advancement	advancement	NOUN
iajs-2138	18	5	of	of	ADP
iajs-2138	18	6	t2	t2	NOUN
iajs-2138	18	7	dm	dm	PROPN
iajs-2138	18	8	in	in	ADP
iajs-2138	18	9	thyroid	thyroid	NOUN
iajs-2138	18	10	disorder	disorder	NOUN
iajs-2138	18	11	patients	patient	NOUN
iajs-2138	18	12	may	may	AUX
iajs-2138	18	13	be	be	AUX
iajs-2138	18	14	related	relate	VERB
iajs-2138	18	15	to	to	ADP
iajs-2138	18	16	disturbed	disturb	VERB
iajs-2138	18	17	genetic	genetic	ADJ
iajs-2138	18	18	expression	expression	NOUN
iajs-2138	18	19	of	of	ADP
iajs-2138	18	20	genes	gene	NOUN
iajs-2138	18	21	in	in	ADP
iajs-2138	18	22	conjunction	conjunction	NOUN
iajs-2138	18	23	with	with	ADP
iajs-2138	18	24	physiological	physiological	ADJ
iajs-2138	18	25	aberrations	aberration	NOUN
iajs-2138	18	26	leading	lead	VERB
iajs-2138	18	27	to	to	ADP
iajs-2138	18	28	impaired	impair	VERB
iajs-2138	18	29	glucose	glucose	NOUN
iajs-2138	18	30	consumption	consumption	NOUN
iajs-2138	18	31	by	by	ADP
iajs-2138	18	32	the	the	DET
iajs-2138	18	33	augmented	augment	VERB
iajs-2138	18	34	hepatic	hepatic	NOUN
iajs-2138	18	35	glucose	glucose	NOUN
iajs-2138	18	36	output	output	NOUN
iajs-2138	18	37	,	,	PUNCT
iajs-2138	18	38	muscles	muscle	NOUN
iajs-2138	18	39	,	,	PUNCT
iajs-2138	18	40	and	and	CCONJ
iajs-2138	18	41	glucose	glucose	NOUN
iajs-2138	18	42	absorption	absorption	NOUN
iajs-2138	18	43	elevation	elevation	NOUN
iajs-2138	18	44	from	from	ADP
iajs-2138	18	45	intestine	intestine	ADJ
iajs-2138	18	46	chitotriosidase-1	chitotriosidase-1	PROPN
iajs-2138	18	47	levels	level	NOUN
iajs-2138	18	48	in	in	ADP
iajs-2138	18	49	iraqi	iraqi	ADJ
iajs-2138	18	50	type	type	NOUN
iajs-2138	18	51	2	2	NUM
iajs-2138	18	52	diabetic	diabetic	ADJ
iajs-2138	18	53	patients	patient	NOUN
iajs-2138	18	54	with	with	ADP
iajs-2138	18	55	thyroid	thyroid	NOUN
iajs-2138	18	56	disorders	disorder	NOUN
iajs-2138	18	57	ibn	ibn	PROPN
iajs-2138	18	58	al	al	PROPN
iajs-2138	18	59	haitham	haitham	PROPN
iajs-2138	18	60	journal	journal	PROPN
iajs-2138	18	61	for	for	ADP
iajs-2138	18	62	pure	pure	ADJ
iajs-2138	18	63	and	and	CCONJ
iajs-2138	18	64	applied	apply	VERB
iajs-2138	18	65	science	science	NOUN
iajs-2138	18	66	journal	journal	PROPN
iajs-2138	18	67	homepage	homepage	NOUN
iajs-2138	18	68	:	:	PUNCT
iajs-2138	18	69	http://jih.uobaghdad.edu.iq/index.php/j/index	http://jih.uobaghdad.edu.iq/index.php/j/index	PROPN
iajs-2138	18	70	mohammed	mohammed	PROPN
iajs-2138	18	71	alwan	alwan	PROPN
iajs-2138	18	72	iedan	iedan	PROPN
iajs-2138	18	73	zeinab	zeinab	PROPN
iajs-2138	18	74	m.	m.	PROPN
iajs-2138	18	75	m.	m.	PROPN
iajs-2138	18	76	al	al	PROPN
iajs-2138	18	77	-	-	PUNCT
iajs-2138	18	78	rubaei	rubaei	PROPN
iajs-2138	18	79	department	department	NOUN
iajs-2138	18	80	of	of	ADP
iajs-2138	18	81	chemistry	chemistry	NOUN
iajs-2138	18	82	,	,	PUNCT
iajs-2138	18	83	college	college	NOUN
iajs-2138	18	84	of	of	ADP
iajs-2138	18	85	education	education	NOUN
iajs-2138	18	86	for	for	ADP
iajs-2138	18	87	pure	pure	ADJ
iajs-2138	18	88	science	science	NOUN
iajs-2138	18	89	ibn	ibn	PROPN
iajs-2138	18	90	–	–	PUNCT
iajs-2138	18	91	al	al	PROPN
iajs-2138	18	92	-	-	PUNCT
iajs-2138	18	93	haitham	haitham	PROPN
iajs-2138	18	94	,	,	PUNCT
iajs-2138	18	95	university	university	PROPN
iajs-2138	18	96	of	of	ADP
iajs-2138	18	97	baghdad	baghdad	PROPN
iajs-2138	18	98	,	,	PUNCT
iajs-2138	18	99	baghdad	baghdad	PROPN
iajs-2138	18	100	,	,	PUNCT
iajs-2138	18	101	iraq	iraq	PROPN
iajs-2138	18	102	.	.	PUNCT
iajs-2138	19	1	article	article	NOUN
iajs-2138	19	2	history	history	NOUN
iajs-2138	19	3	:	:	PUNCT
iajs-2138	19	4	received	receive	VERB
iajs-2138	19	5	21	21	NUM
iajs-2138	19	6	november	november	PROPN
iajs-2138	19	7	2018	2018	NUM
iajs-2138	19	8	,	,	PUNCT
iajs-2138	19	9	accepted	accept	VERB
iajs-2138	19	10	30	30	NUM
iajs-2138	19	11	january	january	NOUN
iajs-2138	19	12	2019	2019	NUM
iajs-2138	19	13	,	,	PUNCT
iajs-2138	19	14	publish	publish	VERB
iajs-2138	19	15	may	may	PROPN
iajs-2138	19	16	2019	2019	NUM
iajs-2138	19	17	mohammadchemist978@gmail.com	mohammadchemist978@gmail.com	X
iajs-2138	20	1	alizeinabah@yahoo.com	alizeinabah@yahoo.com	X
iajs-2138	21	1	doi	doi	NOUN
iajs-2138	21	2	:	:	PUNCT
iajs-2138	21	3	10.30526/32.2.2138	10.30526/32.2.2138	PROPN
iajs-2138	21	4	mailto:mohammadchemist978@gmail.com	mailto:mohammadchemist978@gmail.com	X
iajs-2138	21	5	mailto:tibataiee92@gmail.com	mailto:tibataiee92@gmail.com	AUX
iajs-2138	21	6	mailto:tibataiee92@gmail.com	mailto:tibataiee92@gmail.com	PROPN
iajs-2138	21	7	mailto:tibataiee92@gmail.com	mailto:tibataiee92@gmail.com	PROPN
iajs-2138	21	8	mailto:alizeinabah@yahoo.com	mailto:alizeinabah@yahoo.com	PROPN
iajs-2138	21	9	mailto:alizeinabah@yahoo.com	mailto:alizeinabah@yahoo.com	PROPN
iajs-2138	22	1	54	54	NUM
iajs-2138	23	1	ibn	ibn	PROPN
iajs-2138	23	2	al	al	PROPN
iajs-2138	23	3	-	-	PUNCT
iajs-2138	23	4	haitham	haitham	PROPN
iajs-2138	23	5	jour	jour	X
iajs-2138	23	6	.	.	PROPN
iajs-2138	23	7	for	for	ADP
iajs-2138	23	8	pure	pure	ADJ
iajs-2138	23	9	&	&	CCONJ
iajs-2138	23	10	appl	appl	PROPN
iajs-2138	23	11	.	.	PUNCT
iajs-2138	24	1	sci	sci	PROPN
iajs-2138	24	2	.	.	PROPN
iajs-2138	24	3	32	32	NUM
iajs-2138	24	4	(	(	PUNCT
iajs-2138	24	5	2	2	NUM
iajs-2138	24	6	)	)	PUNCT
iajs-2138	24	7	2019	2019	NUM
iajs-2138	25	1	[	[	X
iajs-2138	25	2	3	3	NUM
iajs-2138	25	3	]	]	PUNCT
iajs-2138	25	4	.	.	PUNCT
iajs-2138	26	1	chitotriosidase-1	chitotriosidase-1	NOUN
iajs-2138	26	2	is	be	AUX
iajs-2138	26	3	known	know	VERB
iajs-2138	26	4	as	as	ADP
iajs-2138	26	5	an	an	DET
iajs-2138	26	6	enzyme	enzyme	NOUN
iajs-2138	26	7	involved	involve	VERB
iajs-2138	26	8	with	with	ADP
iajs-2138	26	9	n	n	CCONJ
iajs-2138	26	10	-	-	PUNCT
iajs-2138	26	11	terminal	terminal	ADJ
iajs-2138	26	12	triose	triose	NOUN
iajs-2138	26	13	phosphate	phosphate	NOUN
iajs-2138	26	14	isomerase	isomerase	ADJ
iajs-2138	26	15	catalytic	catalytic	ADJ
iajs-2138	26	16	groove	groove	NOUN
iajs-2138	26	17	.	.	PUNCT
iajs-2138	27	1	the	the	DET
iajs-2138	27	2	c	c	NOUN
iajs-2138	27	3	-	-	PUNCT
iajs-2138	27	4	terminal	terminal	ADJ
iajs-2138	27	5	chitin	chitin	NOUN
iajs-2138	27	6	-	-	PUNCT
iajs-2138	27	7	binding	bind	VERB
iajs-2138	27	8	domain	domain	NOUN
iajs-2138	27	9	linked	link	VERB
iajs-2138	27	10	by	by	ADP
iajs-2138	27	11	a	a	DET
iajs-2138	27	12	short	short	ADJ
iajs-2138	27	13	hinge	hinge	NOUN
iajs-2138	27	14	region	region	NOUN
iajs-2138	28	1	[	[	X
iajs-2138	28	2	4,5	4,5	NUM
iajs-2138	28	3	]	]	PUNCT
iajs-2138	28	4	.	.	PUNCT
iajs-2138	29	1	chitotriosidase-1	chitotriosidase-1	NOUN
iajs-2138	29	2	are	be	AUX
iajs-2138	29	3	hydrolytic	hydrolytic	ADJ
iajs-2138	29	4	enzymes	enzyme	NOUN
iajs-2138	29	5	that	that	PRON
iajs-2138	29	6	break	break	VERB
iajs-2138	29	7	down	down	ADP
iajs-2138	29	8	glycosidic	glycosidic	ADJ
iajs-2138	29	9	bonds	bond	NOUN
iajs-2138	29	10	in	in	ADP
iajs-2138	29	11	chitin	chitin	NOUN
iajs-2138	29	12	that	that	PRON
iajs-2138	29	13	found	find	VERB
iajs-2138	29	14	in	in	ADP
iajs-2138	29	15	two	two	NUM
iajs-2138	29	16	forms	form	NOUN
iajs-2138	29	17	,	,	PUNCT
iajs-2138	29	18	50	50	NUM
iajs-2138	29	19	kd	kd	NOUN
iajs-2138	29	20	the	the	DET
iajs-2138	29	21	dominant	dominant	ADJ
iajs-2138	29	22	form	form	NOUN
iajs-2138	29	23	in	in	ADP
iajs-2138	29	24	blood	blood	NOUN
iajs-2138	29	25	and	and	CCONJ
iajs-2138	29	26	a	a	DET
iajs-2138	29	27	39	39	NUM
iajs-2138	29	28	kd	kd	NOUN
iajs-2138	29	29	the	the	DET
iajs-2138	29	30	dominant	dominant	ADJ
iajs-2138	29	31	form	form	NOUN
iajs-2138	29	32	in	in	ADP
iajs-2138	29	33	tissues	tissue	NOUN
iajs-2138	29	34	[	[	X
iajs-2138	29	35	4	4	NUM
iajs-2138	29	36	]	]	PUNCT
iajs-2138	29	37	.	.	PUNCT
iajs-2138	30	1	chitotriosidase-1	chitotriosidase-1	NOUN
iajs-2138	30	2	is	be	AUX
iajs-2138	30	3	necessary	necessary	ADJ
iajs-2138	30	4	in	in	ADP
iajs-2138	30	5	chitin	chitin	NOUN
iajs-2138	30	6	digestion	digestion	NOUN
iajs-2138	30	7	by	by	ADP
iajs-2138	30	8	hydrolyzing	hydrolyze	VERB
iajs-2138	30	9	its	its	PRON
iajs-2138	30	10	β-1	β-1	NOUN
iajs-2138	30	11	,	,	PUNCT
iajs-2138	30	12	4	4	NUM
iajs-2138	30	13	glycoside	glycoside	NOUN
iajs-2138	30	14	linkage	linkage	NOUN
iajs-2138	30	15	like	like	ADP
iajs-2138	30	16	a	a	DET
iajs-2138	30	17	defensive	defensive	ADJ
iajs-2138	30	18	action	action	NOUN
iajs-2138	30	19	and/or	and/or	CCONJ
iajs-2138	30	20	utilization	utilization	NOUN
iajs-2138	30	21	of	of	ADP
iajs-2138	30	22	chitin	chitin	NOUN
iajs-2138	30	23	as	as	ADP
iajs-2138	30	24	a	a	DET
iajs-2138	30	25	source	source	NOUN
iajs-2138	30	26	of	of	ADP
iajs-2138	30	27	carbon	carbon	NOUN
iajs-2138	30	28	and	and	CCONJ
iajs-2138	30	29	energy	energy	NOUN
iajs-2138	30	30	[	[	X
iajs-2138	30	31	6	6	NUM
iajs-2138	30	32	]	]	PUNCT
iajs-2138	30	33	.	.	PUNCT
iajs-2138	31	1	enzymatically	enzymatically	ADV
iajs-2138	31	2	active	active	ADJ
iajs-2138	31	3	mammalian	mammalian	ADJ
iajs-2138	31	4	chitinases	chitinase	NOUN
iajs-2138	31	5	cleave	cleave	VERB
iajs-2138	31	6	chitin	chitin	NOUN
iajs-2138	31	7	polymers	polymer	NOUN
iajs-2138	31	8	into	into	ADP
iajs-2138	31	9	oligosaccharides	oligosaccharide	NOUN
iajs-2138	31	10	of	of	ADP
iajs-2138	31	11	varying	vary	VERB
iajs-2138	31	12	sizes	size	NOUN
iajs-2138	31	13	(	(	PUNCT
iajs-2138	31	14	endochitinase	endochitinase	NOUN
iajs-2138	31	15	activity	activity	NOUN
iajs-2138	31	16	)	)	PUNCT
iajs-2138	31	17	and	and	CCONJ
iajs-2138	31	18	release	release	VERB
iajs-2138	31	19	glucosamine	glucosamine	NOUN
iajs-2138	31	20	monosaccharides	monosaccharide	NOUN
iajs-2138	31	21	from	from	ADP
iajs-2138	31	22	the	the	DET
iajs-2138	31	23	end	end	NOUN
iajs-2138	31	24	of	of	ADP
iajs-2138	31	25	a	a	DET
iajs-2138	31	26	chitin	chitin	NOUN
iajs-2138	31	27	polymer	polymer	NOUN
iajs-2138	31	28	(	(	PUNCT
iajs-2138	31	29	exochitinase	exochitinase	ADJ
iajs-2138	31	30	activity	activity	NOUN
iajs-2138	31	31	)	)	PUNCT
iajs-2138	32	1	[	[	X
iajs-2138	32	2	7	7	NUM
iajs-2138	32	3	]	]	PUNCT
iajs-2138	32	4	.	.	PUNCT
iajs-2138	33	1	chitotriosidase1	chitotriosidase1	PROPN
iajs-2138	33	2	has	have	VERB
iajs-2138	33	3	highly	highly	ADV
iajs-2138	33	4	affinity	affinity	NOUN
iajs-2138	33	5	binding	bind	VERB
iajs-2138	33	6	to	to	PART
iajs-2138	33	7	substrate	substrate	VERB
iajs-2138	33	8	in	in	ADP
iajs-2138	33	9	addition	addition	NOUN
iajs-2138	33	10	to	to	ADP
iajs-2138	33	11	its	its	PRON
iajs-2138	33	12	responsible	responsible	ADJ
iajs-2138	33	13	for	for	ADP
iajs-2138	33	14	the	the	DET
iajs-2138	33	15	transglycosylation	transglycosylation	NOUN
iajs-2138	33	16	activity	activity	NOUN
iajs-2138	33	17	of	of	ADP
iajs-2138	33	18	the	the	DET
iajs-2138	33	19	enzyme	enzyme	NOUN
iajs-2138	33	20	even	even	ADV
iajs-2138	33	21	in	in	ADP
iajs-2138	33	22	the	the	DET
iajs-2138	33	23	absence	absence	NOUN
iajs-2138	33	24	of	of	ADP
iajs-2138	33	25	highly	highly	ADV
iajs-2138	33	26	substrate	substrate	NOUN
iajs-2138	33	27	concentrations	concentration	NOUN
iajs-2138	33	28	,	,	PUNCT
iajs-2138	33	29	causing	cause	VERB
iajs-2138	33	30	chitotriosidase-1	chitotriosidase-1	NOUN
iajs-2138	33	31	a	a	DET
iajs-2138	33	32	complete	complete	ADJ
iajs-2138	33	33	independent	independent	ADJ
iajs-2138	33	34	chitinolytic	chitinolytic	ADJ
iajs-2138	33	35	machinery	machinery	NOUN
iajs-2138	33	36	[	[	X
iajs-2138	33	37	810	810	NUM
iajs-2138	33	38	]	]	PUNCT
iajs-2138	33	39	.	.	PUNCT
iajs-2138	34	1	study	study	NOUN
iajs-2138	34	2	are	be	AUX
iajs-2138	34	3	focused	focus	VERB
iajs-2138	34	4	on	on	ADP
iajs-2138	34	5	chitotriosidase-1	chitotriosidase-1	NOUN
iajs-2138	34	6	effects	effect	NOUN
iajs-2138	34	7	through	through	ADP
iajs-2138	34	8	the	the	DET
iajs-2138	34	9	processes	process	NOUN
iajs-2138	34	10	of	of	ADP
iajs-2138	34	11	chitin	chitin	NOUN
iajs-2138	34	12	recognition	recognition	NOUN
iajs-2138	34	13	,	,	PUNCT
iajs-2138	34	14	antigen	antigen	ADJ
iajs-2138	34	15	presentation	presentation	NOUN
iajs-2138	34	16	,	,	PUNCT
iajs-2138	34	17	stimulation	stimulation	NOUN
iajs-2138	34	18	of	of	ADP
iajs-2138	34	19	cell	cell	NOUN
iajs-2138	34	20	mediated	mediate	VERB
iajs-2138	34	21	immunity	immunity	NOUN
iajs-2138	34	22	and	and	CCONJ
iajs-2138	34	23	synergistic	synergistic	ADJ
iajs-2138	34	24	effects	effect	NOUN
iajs-2138	34	25	with	with	ADP
iajs-2138	34	26	proteases	protease	NOUN
iajs-2138	34	27	to	to	PART
iajs-2138	34	28	kill	kill	VERB
iajs-2138	34	29	various	various	ADJ
iajs-2138	34	30	kinds	kind	NOUN
iajs-2138	34	31	of	of	ADP
iajs-2138	34	32	cancer	cancer	NOUN
iajs-2138	34	33	cells	cell	NOUN
iajs-2138	34	34	[	[	X
iajs-2138	34	35	11	11	NUM
iajs-2138	34	36	]	]	PUNCT
iajs-2138	34	37	.	.	PUNCT
iajs-2138	35	1	chitotriosidase-1	chitotriosidase-1	NOUN
iajs-2138	35	2	has	have	AUX
iajs-2138	35	3	been	be	AUX
iajs-2138	35	4	implicated	implicate	VERB
iajs-2138	35	5	in	in	ADP
iajs-2138	35	6	the	the	DET
iajs-2138	35	7	pathogenesis	pathogenesis	NOUN
iajs-2138	35	8	of	of	ADP
iajs-2138	35	9	many	many	ADJ
iajs-2138	35	10	human	human	ADJ
iajs-2138	35	11	diseases	disease	NOUN
iajs-2138	35	12	by	by	ADP
iajs-2138	35	13	improper	improper	ADJ
iajs-2138	35	14	stimulation	stimulation	NOUN
iajs-2138	35	15	of	of	ADP
iajs-2138	35	16	faulty	faulty	ADJ
iajs-2138	35	17	tissue	tissue	NOUN
iajs-2138	35	18	remodeling	remodeling	NOUN
iajs-2138	35	19	and	and	CCONJ
iajs-2138	35	20	inflammation	inflammation	NOUN
iajs-2138	35	21	like	like	ADP
iajs-2138	35	22	nonalcoholic	nonalcoholic	NOUN
iajs-2138	35	23	fatty	fatty	NOUN
iajs-2138	35	24	liver	liver	NOUN
iajs-2138	35	25	disease	disease	NOUN
iajs-2138	35	26	,	,	PUNCT
iajs-2138	35	27	chronic	chronic	ADJ
iajs-2138	35	28	obstructive	obstructive	ADJ
iajs-2138	35	29	pulmonary	pulmonary	ADJ
iajs-2138	35	30	disease	disease	NOUN
iajs-2138	35	31	and	and	CCONJ
iajs-2138	35	32	neurodegenerative	neurodegenerative	ADJ
iajs-2138	35	33	disorders	disorder	NOUN
iajs-2138	35	34	like	like	ADP
iajs-2138	35	35	alzheimer	alzheimer	PROPN
iajs-2138	35	36	’s	’s	PART
iajs-2138	35	37	disease	disease	NOUN
iajs-2138	35	38	and	and	CCONJ
iajs-2138	35	39	amyotrophic	amyotrophic	ADJ
iajs-2138	35	40	lateral	lateral	ADJ
iajs-2138	35	41	sclerosis	sclerosis	NOUN
iajs-2138	36	1	[	[	X
iajs-2138	36	2	12	12	NUM
iajs-2138	36	3	-	-	SYM
iajs-2138	36	4	14	14	NUM
iajs-2138	36	5	]	]	PUNCT
iajs-2138	36	6	.	.	PUNCT
iajs-2138	37	1	the	the	DET
iajs-2138	37	2	aim	aim	NOUN
iajs-2138	37	3	of	of	ADP
iajs-2138	37	4	the	the	DET
iajs-2138	37	5	present	present	ADJ
iajs-2138	37	6	study	study	NOUN
iajs-2138	37	7	was	be	AUX
iajs-2138	37	8	to	to	PART
iajs-2138	37	9	determine	determine	VERB
iajs-2138	37	10	the	the	DET
iajs-2138	37	11	chitotriosidase-1	chitotriosidase-1	PROPN
iajs-2138	37	12	levels	level	NOUN
iajs-2138	37	13	in	in	ADP
iajs-2138	37	14	iraqi	iraqi	ADJ
iajs-2138	37	15	diabetic	diabetic	ADJ
iajs-2138	37	16	patients	patient	NOUN
iajs-2138	37	17	with	with	ADP
iajs-2138	37	18	thyroid	thyroid	NOUN
iajs-2138	37	19	disorders	disorder	NOUN
iajs-2138	37	20	,	,	PUNCT
iajs-2138	37	21	and	and	CCONJ
iajs-2138	37	22	the	the	DET
iajs-2138	37	23	study	study	NOUN
iajs-2138	37	24	aimed	aim	VERB
iajs-2138	37	25	to	to	PART
iajs-2138	37	26	found	find	VERB
iajs-2138	37	27	relation	relation	NOUN
iajs-2138	37	28	correlation	correlation	NOUN
iajs-2138	37	29	for	for	ADP
iajs-2138	37	30	chitotriosidase-1	chitotriosidase-1	PROPN
iajs-2138	37	31	with	with	ADP
iajs-2138	37	32	t3	t3	PROPN
iajs-2138	37	33	,	,	PUNCT
iajs-2138	37	34	t4	t4	PROPN
iajs-2138	37	35	and	and	CCONJ
iajs-2138	37	36	tsh	tsh	NOUN
iajs-2138	37	37	.	.	PROPN
iajs-2138	37	38	2	2	NUM
iajs-2138	37	39	.	.	X
iajs-2138	37	40	materials	material	NOUN
iajs-2138	37	41	and	and	CCONJ
iajs-2138	37	42	methods	method	NOUN
iajs-2138	37	43	a	a	DET
iajs-2138	37	44	prospective	prospective	ADJ
iajs-2138	37	45	study	study	NOUN
iajs-2138	37	46	was	be	AUX
iajs-2138	37	47	conducted	conduct	VERB
iajs-2138	37	48	on	on	ADP
iajs-2138	37	49	three	three	NUM
iajs-2138	37	50	groups	group	NOUN
iajs-2138	37	51	of	of	ADP
iajs-2138	37	52	subjects	subject	NOUN
iajs-2138	37	53	during	during	ADP
iajs-2138	37	54	the	the	DET
iajs-2138	37	55	period	period	NOUN
iajs-2138	37	56	from	from	ADP
iajs-2138	37	57	june	june	PROPN
iajs-2138	37	58	(	(	PUNCT
iajs-2138	37	59	2018	2018	NUM
iajs-2138	37	60	)	)	PUNCT
iajs-2138	37	61	to	to	ADP
iajs-2138	37	62	august	august	PROPN
iajs-2138	37	63	(	(	PUNCT
iajs-2138	37	64	2018	2018	NUM
iajs-2138	37	65	)	)	PUNCT
iajs-2138	37	66	at	at	ADP
iajs-2138	37	67	the	the	DET
iajs-2138	37	68	specialized	specialized	ADJ
iajs-2138	37	69	center	center	NOUN
iajs-2138	37	70	for	for	ADP
iajs-2138	37	71	endocrinology	endocrinology	NOUN
iajs-2138	37	72	and	and	CCONJ
iajs-2138	37	73	diabetes	diabetes	NOUN
iajs-2138	37	74	/	/	SYM
iajs-2138	37	75	baghdad	baghdad	PROPN
iajs-2138	37	76	.	.	PUNCT
iajs-2138	38	1	the	the	DET
iajs-2138	38	2	age	age	NOUN
iajs-2138	38	3	range	range	NOUN
iajs-2138	38	4	of	of	ADP
iajs-2138	38	5	all	all	DET
iajs-2138	38	6	subjects	subject	NOUN
iajs-2138	38	7	was	be	AUX
iajs-2138	38	8	(	(	PUNCT
iajs-2138	38	9	40	40	NUM
iajs-2138	38	10	-	-	SYM
iajs-2138	38	11	65	65	NUM
iajs-2138	38	12	)	)	PUNCT
iajs-2138	38	13	years	year	NOUN
iajs-2138	38	14	.	.	PUNCT
iajs-2138	39	1	ninety	ninety	NUM
iajs-2138	39	2	subjects	subject	NOUN
iajs-2138	39	3	were	be	AUX
iajs-2138	39	4	included	include	VERB
iajs-2138	39	5	3	3	NUM
iajs-2138	39	6	groups	group	NOUN
iajs-2138	39	7	in	in	ADP
iajs-2138	39	8	this	this	DET
iajs-2138	39	9	study	study	NOUN
iajs-2138	39	10	that	that	PRON
iajs-2138	39	11	divided	divide	VERB
iajs-2138	39	12	into	into	ADP
iajs-2138	39	13	control	control	NOUN
iajs-2138	39	14	group	group	NOUN
iajs-2138	39	15	g1	g1	PROPN
iajs-2138	39	16	)	)	PUNCT
iajs-2138	39	17	that	that	PRON
iajs-2138	39	18	consisted	consist	VERB
iajs-2138	39	19	of	of	ADP
iajs-2138	39	20	(	(	PUNCT
iajs-2138	39	21	30	30	NUM
iajs-2138	39	22	)	)	PUNCT
iajs-2138	39	23	healthy	healthy	ADJ
iajs-2138	39	24	individuals	individual	NOUN
iajs-2138	39	25	who	who	PRON
iajs-2138	39	26	have	have	VERB
iajs-2138	39	27	no	no	DET
iajs-2138	39	28	history	history	NOUN
iajs-2138	39	29	of	of	ADP
iajs-2138	39	30	any	any	DET
iajs-2138	39	31	thyroid	thyroid	NOUN
iajs-2138	39	32	disorders	disorder	NOUN
iajs-2138	39	33	or	or	CCONJ
iajs-2138	39	34	dm	dm	PROPN
iajs-2138	39	35	.	.	PROPN
iajs-2138	39	36	group	group	NOUN
iajs-2138	39	37	(	(	PUNCT
iajs-2138	39	38	g2	g2	PROPN
iajs-2138	39	39	)	)	PUNCT
iajs-2138	39	40	(	(	PUNCT
iajs-2138	39	41	n=30	n=30	NOUN
iajs-2138	39	42	)	)	PUNCT
iajs-2138	39	43	that	that	PRON
iajs-2138	39	44	consisted	consist	VERB
iajs-2138	39	45	of	of	ADP
iajs-2138	39	46	diabetic	diabetic	ADJ
iajs-2138	39	47	patients	patient	NOUN
iajs-2138	39	48	and	and	CCONJ
iajs-2138	39	49	hyperthyroidism	hyperthyroidism	NOUN
iajs-2138	39	50	as	as	ADP
iajs-2138	39	51	associated	associated	ADJ
iajs-2138	39	52	disease	disease	NOUN
iajs-2138	39	53	,	,	PUNCT
iajs-2138	39	54	and	and	CCONJ
iajs-2138	39	55	group	group	NOUN
iajs-2138	39	56	(	(	PUNCT
iajs-2138	39	57	g3	g3	PROPN
iajs-2138	39	58	)	)	PUNCT
iajs-2138	39	59	(	(	PUNCT
iajs-2138	39	60	n=30	n=30	CCONJ
iajs-2138	39	61	)	)	PUNCT
iajs-2138	39	62	include	include	VERB
iajs-2138	39	63	diabetic	diabetic	ADJ
iajs-2138	39	64	patients	patient	NOUN
iajs-2138	39	65	and	and	CCONJ
iajs-2138	39	66	hypothyroidism	hypothyroidism	NOUN
iajs-2138	39	67	as	as	ADP
iajs-2138	39	68	associated	associated	ADJ
iajs-2138	39	69	disease	disease	NOUN
iajs-2138	39	70	.	.	PUNCT
iajs-2138	40	1	2.1	2.1	NUM
iajs-2138	40	2	.	.	PUNCT
iajs-2138	40	3	blood	blood	NOUN
iajs-2138	40	4	sample	sample	NOUN
iajs-2138	40	5	collection	collection	NOUN
iajs-2138	40	6	five	five	NUM
iajs-2138	40	7	milliliters	milliliter	NOUN
iajs-2138	40	8	of	of	ADP
iajs-2138	40	9	peripheral	peripheral	ADJ
iajs-2138	40	10	veins	vein	NOUN
iajs-2138	40	11	blood	blood	NOUN
iajs-2138	40	12	were	be	AUX
iajs-2138	40	13	taken	take	VERB
iajs-2138	40	14	from	from	ADP
iajs-2138	40	15	all	all	DET
iajs-2138	40	16	subjects	subject	NOUN
iajs-2138	40	17	in	in	ADP
iajs-2138	40	18	plain	plain	ADJ
iajs-2138	40	19	tubes	tube	NOUN
iajs-2138	40	20	.	.	PUNCT
iajs-2138	41	1	serum	serum	PROPN
iajs-2138	41	2	obtained	obtain	VERB
iajs-2138	41	3	stored	store	VERB
iajs-2138	41	4	at	at	ADP
iajs-2138	41	5	(	(	PUNCT
iajs-2138	41	6	-20ºc	-20ºc	NOUN
iajs-2138	41	7	)	)	PUNCT
iajs-2138	41	8	until	until	ADP
iajs-2138	41	9	assay	assay	NOUN
iajs-2138	41	10	time	time	NOUN
iajs-2138	41	11	for	for	ADP
iajs-2138	41	12	analysis	analysis	NOUN
iajs-2138	41	13	of	of	ADP
iajs-2138	41	14	fsg	fsg	PROPN
iajs-2138	41	15	,	,	PUNCT
iajs-2138	41	16	t3	t3	PROPN
iajs-2138	41	17	,	,	PUNCT
iajs-2138	41	18	t4	t4	PROPN
iajs-2138	41	19	,	,	PUNCT
iajs-2138	41	20	tsh	tsh	NOUN
iajs-2138	41	21	and	and	CCONJ
iajs-2138	41	22	chitotriosidase-1	chitotriosidase-1	PROPN
iajs-2138	41	23	.	.	PUNCT
iajs-2138	42	1	determination	determination	NOUN
iajs-2138	42	2	of	of	ADP
iajs-2138	42	3	fasting	fast	VERB
iajs-2138	42	4	serum	serum	NOUN
iajs-2138	42	5	glucose	glucose	NOUN
iajs-2138	42	6	2.2	2.2	NUM
iajs-2138	42	7	.	.	PUNCT
iajs-2138	43	1	an	an	DET
iajs-2138	43	2	enzymatic	enzymatic	ADJ
iajs-2138	43	3	colorimetric	colorimetric	ADJ
iajs-2138	43	4	method	method	NOUN
iajs-2138	43	5	was	be	AUX
iajs-2138	43	6	used	use	VERB
iajs-2138	43	7	for	for	ADP
iajs-2138	43	8	determination	determination	NOUN
iajs-2138	43	9	of	of	ADP
iajs-2138	43	10	fasting	fast	VERB
iajs-2138	43	11	serum	serum	NOUN
iajs-2138	43	12	glucose	glucose	NOUN
iajs-2138	43	13	(	(	PUNCT
iajs-2138	43	14	fsg	fsg	NOUN
iajs-2138	43	15	)	)	PUNCT
iajs-2138	43	16	based	base	VERB
iajs-2138	43	17	on	on	ADP
iajs-2138	43	18	trinder	trinder	ADJ
iajs-2138	43	19	hydrogen	hydrogen	NOUN
iajs-2138	43	20	peroxide	peroxide	NOUN
iajs-2138	43	21	and	and	CCONJ
iajs-2138	43	22	the	the	DET
iajs-2138	43	23	phenol	phenol	NOUN
iajs-2138	43	24	and	and	CCONJ
iajs-2138	43	25	4	4	NUM
iajs-2138	43	26	-	-	NUM
iajs-2138	43	27	aminoantipyrine	aminoantipyrine	NOUN
iajs-2138	43	28	.	.	PUNCT
iajs-2138	44	1	the	the	DET
iajs-2138	44	2	quinine(complex	quinine(complex	PROPN
iajs-2138	44	3	)	)	PUNCT
iajs-2138	44	4	red	red	ADJ
iajs-2138	44	5	-	-	PUNCT
iajs-2138	44	6	violet	violet	NOUN
iajs-2138	44	7	in	in	ADP
iajs-2138	44	8	colour	colour	NOUN
iajs-2138	44	9	,	,	PUNCT
iajs-2138	44	10	measured	measure	VERB
iajs-2138	44	11	at	at	ADP
iajs-2138	44	12	505	505	NUM
iajs-2138	44	13	nm	nm	NOUN
iajs-2138	44	14	,	,	PUNCT
iajs-2138	44	15	510	510	NUM
iajs-2138	44	16	nm	nm	NOUN
iajs-2138	44	17	with	with	ADP
iajs-2138	44	18	the	the	DET
iajs-2138	44	19	intensity	intensity	NOUN
iajs-2138	44	20	of	of	ADP
iajs-2138	44	21	the	the	DET
iajs-2138	44	22	colour	colour	NOUN
iajs-2138	44	23	being	be	AUX
iajs-2138	44	24	in	in	ADP
iajs-2138	44	25	proportion	proportion	NOUN
iajs-2138	44	26	to	to	ADP
iajs-2138	44	27	the	the	DET
iajs-2138	44	28	glucose	glucose	NOUN
iajs-2138	44	29	concentration	concentration	NOUN
iajs-2138	44	30	[	[	X
iajs-2138	44	31	15	15	NUM
iajs-2138	44	32	]	]	SYM
iajs-2138	44	33	.	.	PUNCT
iajs-2138	45	1	2.3	2.3	NUM
iajs-2138	45	2	.	.	PUNCT
iajs-2138	46	1	determination	determination	NOUN
iajs-2138	46	2	of	of	ADP
iajs-2138	46	3	triiodothyronine	triiodothyronine	NOUN
iajs-2138	46	4	(	(	PUNCT
iajs-2138	46	5	t3	t3	PROPN
iajs-2138	46	6	)	)	PUNCT
iajs-2138	46	7	,	,	PUNCT
iajs-2138	46	8	thyroxine	thyroxine	NOUN
iajs-2138	46	9	(	(	PUNCT
iajs-2138	46	10	t4	t4	PROPN
iajs-2138	46	11	)	)	PUNCT
iajs-2138	46	12	,	,	PUNCT
iajs-2138	46	13	and	and	CCONJ
iajs-2138	46	14	thyroid	thyroid	VERB
iajs-2138	46	15	stimulating	stimulate	VERB
iajs-2138	46	16	hormone	hormone	NOUN
iajs-2138	46	17	(	(	PUNCT
iajs-2138	46	18	tsh	tsh	PROPN
iajs-2138	46	19	)	)	PUNCT
iajs-2138	46	20	the	the	DET
iajs-2138	46	21	t3	t3	PROPN
iajs-2138	46	22	,	,	PUNCT
iajs-2138	46	23	t4	t4	PROPN
iajs-2138	46	24	and	and	CCONJ
iajs-2138	46	25	tsh	tsh	NOUN
iajs-2138	46	26	were	be	AUX
iajs-2138	46	27	determined	determine	VERB
iajs-2138	46	28	by	by	ADP
iajs-2138	46	29	enzyme	enzyme	NOUN
iajs-2138	46	30	linked	link	VERB
iajs-2138	46	31	fluorescent	fluorescent	ADJ
iajs-2138	46	32	immunoassay	immunoassay	NOUN
iajs-2138	46	33	(	(	PUNCT
iajs-2138	46	34	elfa	elfa	NOUN
iajs-2138	46	35	)	)	PUNCT
iajs-2138	46	36	competition	competition	NOUN
iajs-2138	46	37	method	method	NOUN
iajs-2138	46	38	with	with	ADP
iajs-2138	46	39	a	a	DET
iajs-2138	46	40	final	final	ADJ
iajs-2138	46	41	detection	detection	NOUN
iajs-2138	47	1	[	[	X
iajs-2138	47	2	16	16	NUM
iajs-2138	47	3	]	]	PUNCT
iajs-2138	47	4	.	.	PUNCT
iajs-2138	48	1	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc3579558/#r5	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc3579558/#r5	NUM
iajs-2138	48	2	https://en.wikipedia.org/wiki/enzyme	https://en.wikipedia.org/wiki/enzyme	PROPN
iajs-2138	48	3	https://en.wikipedia.org/wiki/glycosidic_bond	https://en.wikipedia.org/wiki/glycosidic_bond	NOUN
iajs-2138	48	4	https://en.wikipedia.org/wiki/chitin	https://en.wikipedia.org/wiki/chitin	PROPN
iajs-2138	48	5	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc3579558/#r19	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc3579558/#r19	PROPN
iajs-2138	48	6	http://wapedia.mobi/en/hydrogen_peroxide	http://wapedia.mobi/en/hydrogen_peroxide	ADP
iajs-2138	48	7	54	54	NUM
iajs-2138	48	8	ibn	ibn	PROPN
iajs-2138	48	9	al	al	PROPN
iajs-2138	48	10	-	-	PUNCT
iajs-2138	48	11	haitham	haitham	PROPN
iajs-2138	48	12	jour	jour	X
iajs-2138	48	13	.	.	PROPN
iajs-2138	49	1	for	for	ADP
iajs-2138	49	2	pure	pure	ADJ
iajs-2138	49	3	&	&	CCONJ
iajs-2138	49	4	appl	appl	PROPN
iajs-2138	49	5	.	.	PUNCT
iajs-2138	50	1	sci	sci	PROPN
iajs-2138	50	2	.	.	PROPN
iajs-2138	50	3	32	32	NUM
iajs-2138	50	4	(	(	PUNCT
iajs-2138	50	5	2	2	NUM
iajs-2138	50	6	)	)	PUNCT
iajs-2138	50	7	2019	2019	NUM
iajs-2138	50	8	2.4	2.4	NUM
iajs-2138	50	9	.	.	PUNCT
iajs-2138	51	1	determination	determination	NOUN
iajs-2138	51	2	of	of	ADP
iajs-2138	51	3	chitotriosidase-1	chitotriosidase-1	NOUN
iajs-2138	51	4	sandwich	sandwich	NOUN
iajs-2138	51	5	enzyme	enzyme	NOUN
iajs-2138	51	6	linked	link	VERB
iajs-2138	51	7	immune	immune	ADJ
iajs-2138	51	8	sorbent	sorbent	NOUN
iajs-2138	51	9	assay	assay	NOUN
iajs-2138	51	10	(	(	PUNCT
iajs-2138	51	11	elisa	elisa	NOUN
iajs-2138	51	12	)	)	PUNCT
iajs-2138	51	13	technique	technique	NOUN
iajs-2138	51	14	was	be	AUX
iajs-2138	51	15	used	use	VERB
iajs-2138	51	16	for	for	ADP
iajs-2138	51	17	determination	determination	NOUN
iajs-2138	51	18	of	of	ADP
iajs-2138	51	19	chitotriosidase-1	chitotriosidase-1	NOUN
iajs-2138	51	20	by	by	ADP
iajs-2138	51	21	ready	ready	ADJ
iajs-2138	51	22	kit	kit	NOUN
iajs-2138	51	23	from	from	ADP
iajs-2138	51	24	my	my	PRON
iajs-2138	51	25	bio	bio	NOUN
iajs-2138	51	26	source	source	NOUN
iajs-2138	51	27	,	,	PUNCT
iajs-2138	51	28	cat.no	cat.no	NUM
iajs-2138	51	29	.	.	PUNCT
iajs-2138	51	30	:	:	PUNCT
iajs-2138	51	31	mbs765849	mbs765849	NOUN
iajs-2138	51	32	.	.	PUNCT
iajs-2138	52	1	3	3	X
iajs-2138	52	2	.	.	X
iajs-2138	52	3	statistical	statistical	ADJ
iajs-2138	52	4	analyses	analysis	NOUN
iajs-2138	52	5	the	the	DET
iajs-2138	52	6	results	result	NOUN
iajs-2138	52	7	were	be	AUX
iajs-2138	52	8	expressed	express	VERB
iajs-2138	52	9	as	as	ADP
iajs-2138	52	10	mean	mean	ADJ
iajs-2138	52	11	±sd	±sd	PROPN
iajs-2138	52	12	.	.	PUNCT
iajs-2138	53	1	students	student	NOUN
iajs-2138	53	2	t	t	PROPN
iajs-2138	53	3	-	-	PUNCT
iajs-2138	53	4	test	test	NOUN
iajs-2138	53	5	was	be	AUX
iajs-2138	53	6	applied	apply	VERB
iajs-2138	53	7	to	to	PART
iajs-2138	53	8	compare	compare	VERB
iajs-2138	53	9	the	the	DET
iajs-2138	53	10	significant	significant	NOUN
iajs-2138	53	11	of	of	ADP
iajs-2138	53	12	the	the	DET
iajs-2138	53	13	difference	difference	NOUN
iajs-2138	53	14	among	among	ADP
iajs-2138	53	15	the	the	DET
iajs-2138	53	16	groups	group	NOUN
iajs-2138	53	17	.	.	PUNCT
iajs-2138	54	1	p	p	X
iajs-2138	54	2	-	-	PUNCT
iajs-2138	54	3	value	value	NOUN
iajs-2138	54	4	(	(	PUNCT
iajs-2138	54	5	p≥	p≥	NOUN
iajs-2138	54	6	0.05	0.05	NUM
iajs-2138	54	7	)	)	PUNCT
iajs-2138	54	8	,	,	PUNCT
iajs-2138	54	9	(	(	PUNCT
iajs-2138	54	10	p≤0.05	p≤0.05	NOUN
iajs-2138	54	11	)	)	PUNCT
iajs-2138	54	12	,	,	PUNCT
iajs-2138	54	13	(	(	PUNCT
iajs-2138	54	14	p≤0.01	p≤0.01	NOUN
iajs-2138	54	15	)	)	PUNCT
iajs-2138	54	16	were	be	AUX
iajs-2138	54	17	considered	consider	VERB
iajs-2138	54	18	statically	statically	ADV
iajs-2138	54	19	non	non	ADJ
iajs-2138	54	20	-	-	ADJ
iajs-2138	54	21	significant	significant	ADJ
iajs-2138	54	22	,	,	PUNCT
iajs-2138	54	23	significant	significant	ADJ
iajs-2138	54	24	,	,	PUNCT
iajs-2138	54	25	and	and	CCONJ
iajs-2138	54	26	highly	highly	ADV
iajs-2138	54	27	significant	significant	ADJ
iajs-2138	54	28	respectively	respectively	ADV
iajs-2138	54	29	.	.	PUNCT
iajs-2138	55	1	the	the	DET
iajs-2138	55	2	correlation	correlation	NOUN
iajs-2138	55	3	coefficient	coefficient	NOUN
iajs-2138	55	4	test	test	NOUN
iajs-2138	55	5	used	use	VERB
iajs-2138	55	6	for	for	ADP
iajs-2138	55	7	illustration	illustration	NOUN
iajs-2138	55	8	the	the	DET
iajs-2138	55	9	association	association	NOUN
iajs-2138	55	10	between	between	ADP
iajs-2138	55	11	the	the	DET
iajs-2138	55	12	various	various	ADJ
iajs-2138	55	13	parameters	parameter	NOUN
iajs-2138	55	14	that	that	PRON
iajs-2138	55	15	studied	study	VERB
iajs-2138	55	16	.	.	PUNCT
iajs-2138	56	1	3	3	X
iajs-2138	56	2	.	.	X
iajs-2138	56	3	results	result	NOUN
iajs-2138	56	4	&	&	CCONJ
iajs-2138	56	5	discussion	discussion	NOUN
iajs-2138	56	6	:	:	PUNCT
iajs-2138	56	7	descriptive	descriptive	ADJ
iajs-2138	56	8	parameters	parameter	NOUN
iajs-2138	56	9	were	be	AUX
iajs-2138	56	10	presented	present	VERB
iajs-2138	56	11	in	in	ADP
iajs-2138	56	12	table	table	NOUN
iajs-2138	56	13	1	1	NUM
iajs-2138	56	14	,	,	PUNCT
iajs-2138	56	15	which	which	PRON
iajs-2138	56	16	display	display	VERB
iajs-2138	56	17	the	the	DET
iajs-2138	56	18	levels	level	NOUN
iajs-2138	56	19	of	of	ADP
iajs-2138	56	20	fsg	fsg	PROPN
iajs-2138	56	21	,	,	PUNCT
iajs-2138	56	22	t3	t3	PROPN
iajs-2138	56	23	,	,	PUNCT
iajs-2138	56	24	t4	t4	PROPN
iajs-2138	56	25	and	and	CCONJ
iajs-2138	56	26	tsh	tsh	NOUN
iajs-2138	56	27	for	for	ADP
iajs-2138	56	28	all	all	DET
iajs-2138	56	29	studied	study	VERB
iajs-2138	56	30	groups	group	NOUN
iajs-2138	56	31	.	.	PUNCT
iajs-2138	57	1	table	table	NOUN
iajs-2138	57	2	1	1	NUM
iajs-2138	57	3	,	,	PUNCT
iajs-2138	57	4	showed	show	VERB
iajs-2138	57	5	a	a	DET
iajs-2138	57	6	highly	highly	ADV
iajs-2138	57	7	significant	significant	ADJ
iajs-2138	57	8	elevation	elevation	NOUN
iajs-2138	57	9	in	in	ADP
iajs-2138	57	10	patients	patient	NOUN
iajs-2138	57	11	’	'	PUNCT
iajs-2138	57	12	groups	group	NOUN
iajs-2138	57	13	(	(	PUNCT
iajs-2138	57	14	g2	g2	PROPN
iajs-2138	57	15	,	,	PUNCT
iajs-2138	57	16	g3	g3	PROPN
iajs-2138	57	17	)	)	PUNCT
iajs-2138	57	18	comparing	compare	VERB
iajs-2138	57	19	to	to	AUX
iajs-2138	57	20	control	control	NOUN
iajs-2138	57	21	group	group	NOUN
iajs-2138	57	22	in	in	ADP
iajs-2138	57	23	fsg	fsg	PROPN
iajs-2138	57	24	levels	level	NOUN
iajs-2138	57	25	.	.	PUNCT
iajs-2138	58	1	in	in	ADP
iajs-2138	58	2	addition	addition	NOUN
iajs-2138	58	3	,	,	PUNCT
iajs-2138	58	4	a	a	DET
iajs-2138	58	5	significant	significant	ADJ
iajs-2138	58	6	elevation	elevation	NOUN
iajs-2138	58	7	in	in	ADP
iajs-2138	58	8	g3	g3	PROPN
iajs-2138	58	9	compared	compare	VERB
iajs-2138	58	10	to	to	ADP
iajs-2138	58	11	g2	g2	PROPN
iajs-2138	58	12	was	be	AUX
iajs-2138	58	13	found	find	VERB
iajs-2138	58	14	.	.	PUNCT
iajs-2138	59	1	table	table	NOUN
iajs-2138	59	2	1	1	NUM
iajs-2138	59	3	.	.	PUNCT
iajs-2138	60	1	levels	level	NOUN
iajs-2138	60	2	of	of	ADP
iajs-2138	60	3	fsg	fsg	PROPN
iajs-2138	60	4	,	,	PUNCT
iajs-2138	60	5	t3	t3	PROPN
iajs-2138	60	6	,	,	PUNCT
iajs-2138	60	7	t4	t4	PROPN
iajs-2138	60	8	and	and	CCONJ
iajs-2138	60	9	tsh	tsh	NOUN
iajs-2138	60	10	and	and	CCONJ
iajs-2138	60	11	chitotriosidase-1	chitotriosidase-1	NOUN
iajs-2138	60	12	for	for	ADP
iajs-2138	60	13	g1	g1	NOUN
iajs-2138	60	14	,	,	PUNCT
iajs-2138	60	15	g2	g2	PROPN
iajs-2138	60	16	,	,	PUNCT
iajs-2138	60	17	g3	g3	PROPN
iajs-2138	60	18	.	.	PUNCT
iajs-2138	61	1	parameters	parameter	NOUN
iajs-2138	61	2	mean±sd	mean±sd	ADP
iajs-2138	61	3	(	(	PUNCT
iajs-2138	61	4	g1	g1	PROPN
iajs-2138	61	5	)	)	PUNCT
iajs-2138	61	6	mean±sd	mean±sd	PROPN
iajs-2138	61	7	(	(	PUNCT
iajs-2138	61	8	g2	g2	PROPN
iajs-2138	61	9	)	)	PUNCT
iajs-2138	62	1	mean±sd	mean±sd	PROPN
iajs-2138	62	2	(	(	PUNCT
iajs-2138	62	3	g3	g3	PROPN
iajs-2138	62	4	)	)	PUNCT
iajs-2138	62	5	t	t	PROPN
iajs-2138	62	6	-	-	PUNCT
iajs-2138	62	7	test	test	NOUN
iajs-2138	62	8	g1	g1	PROPN
iajs-2138	62	9	vs	vs	ADP
iajs-2138	62	10	g2	g2	PROPN
iajs-2138	62	11	t	t	PROPN
iajs-2138	62	12	-	-	PUNCT
iajs-2138	62	13	test	test	NOUN
iajs-2138	62	14	g2	g2	PROPN
iajs-2138	62	15	vs	vs	ADP
iajs-2138	62	16	g3	g3	PROPN
iajs-2138	62	17	t	t	PROPN
iajs-2138	62	18	-	-	PUNCT
iajs-2138	62	19	test	test	NOUN
iajs-2138	62	20	g1	g1	PROPN
iajs-2138	62	21	vs	vs	ADP
iajs-2138	62	22	g3	g3	PROPN
iajs-2138	62	23	fsg	fsg	PROPN
iajs-2138	62	24	(	(	PUNCT
iajs-2138	62	25	mmol	mmol	NOUN
iajs-2138	62	26	/	/	SYM
iajs-2138	62	27	l	l	NOUN
iajs-2138	62	28	)	)	PUNCT
iajs-2138	62	29	4.356±0.76	4.356±0.76	NUM
iajs-2138	63	1	10.607±2.533	10.607±2.533	NUM
iajs-2138	63	2	11.091±2.935	11.091±2.935	NUM
iajs-2138	63	3	p≤0.01	p≤0.01	NOUN
iajs-2138	63	4	p≤0.05	p≤0.05	NOUN
iajs-2138	63	5	p≤0.01	p≤0.01	NOUN
iajs-2138	63	6	t3(nmol	t3(nmol	NUM
iajs-2138	63	7	/	/	SYM
iajs-2138	63	8	l	l	NOUN
iajs-2138	63	9	)	)	PUNCT
iajs-2138	64	1	1.66±0.384	1.66±0.384	NOUN
iajs-2138	64	2	2.78±0.170	2.78±0.170	NUM
iajs-2138	64	3	1.09±0.068	1.09±0.068	INTJ
iajs-2138	64	4	p≤0.05	p≤0.05	NOUN
iajs-2138	64	5	p≤0.05	p≤0.05	NOUN
iajs-2138	64	6	p≤0.05	p≤0.05	NOUN
iajs-2138	64	7	t4(nmol	t4(nmol	NOUN
iajs-2138	64	8	/	/	SYM
iajs-2138	64	9	l	l	NOUN
iajs-2138	64	10	)	)	PUNCT
iajs-2138	65	1	82.3±9.450	82.3±9.450	NUM
iajs-2138	65	2	145.21±27.90	145.21±27.90	NUM
iajs-2138	65	3	48.71±15.507	48.71±15.507	NOUN
iajs-2138	65	4	p≤0.05	p≤0.05	NOUN
iajs-2138	65	5	p≤0.05	p≤0.05	NOUN
iajs-2138	65	6	p≤0.05	p≤0.05	NOUN
iajs-2138	65	7	tsh(nmol	tsh(nmol	NOUN
iajs-2138	65	8	/	/	SYM
iajs-2138	65	9	l	l	NOUN
iajs-2138	65	10	)	)	PUNCT
iajs-2138	66	1	2.15±0.411	2.15±0.411	NUM
iajs-2138	66	2	0.154±0.06	0.154±0.06	NUM
iajs-2138	66	3	21.43±4.827	21.43±4.827	NUM
iajs-2138	67	1	p≤0.01	p≤0.01	NOUN
iajs-2138	67	2	p≤0.01	p≤0.01	NOUN
iajs-2138	67	3	p≤0.01	p≤0.01	NOUN
iajs-2138	67	4	chitotriosidase-1	chitotriosidase-1	PROPN
iajs-2138	67	5	(	(	PUNCT
iajs-2138	67	6	ng	ng	PROPN
iajs-2138	67	7	/	/	SYM
iajs-2138	67	8	ml	ml	ADJ
iajs-2138	67	9	)	)	PUNCT
iajs-2138	67	10	0.045±0.003	0.045±0.003	NOUN
iajs-2138	67	11	0.597±0.072	0.597±0.072	X
iajs-2138	68	1	0.09±0.005	0.09±0.005	X
iajs-2138	68	2	p≤0.01	p≤0.01	NOUN
iajs-2138	68	3	p≤0.01	p≤0.01	NOUN
iajs-2138	69	1	p≤0.01	p≤0.01	NOUN
iajs-2138	69	2	*	*	PUNCT
iajs-2138	69	3	g1	g1	PROPN
iajs-2138	69	4	:	:	PUNCT
iajs-2138	69	5	control	control	NOUN
iajs-2138	69	6	group	group	NOUN
iajs-2138	69	7	.	.	PUNCT
iajs-2138	70	1	g2	g2	PROPN
iajs-2138	70	2	:	:	PUNCT
iajs-2138	70	3	diabetic	diabetic	ADJ
iajs-2138	70	4	group	group	NOUN
iajs-2138	70	5	.	.	PUNCT
iajs-2138	71	1	g3	g3	PROPN
iajs-2138	71	2	:	:	PUNCT
iajs-2138	71	3	diabetic	diabetic	ADJ
iajs-2138	71	4	neuropathy	neuropathy	ADJ
iajs-2138	71	5	group	group	NOUN
iajs-2138	71	6	.	.	PUNCT
iajs-2138	72	1	results	result	NOUN
iajs-2138	72	2	,	,	PUNCT
iajs-2138	72	3	also	also	ADV
iajs-2138	72	4	,	,	PUNCT
iajs-2138	72	5	revealed	reveal	VERB
iajs-2138	72	6	a	a	DET
iajs-2138	72	7	significant	significant	ADJ
iajs-2138	72	8	increase	increase	NOUN
iajs-2138	72	9	in	in	ADP
iajs-2138	72	10	levels	level	NOUN
iajs-2138	72	11	of	of	ADP
iajs-2138	72	12	t3	t3	PROPN
iajs-2138	72	13	and	and	CCONJ
iajs-2138	72	14	t4	t4	PROPN
iajs-2138	72	15	in	in	ADP
iajs-2138	72	16	g2	g2	PROPN
iajs-2138	72	17	when	when	SCONJ
iajs-2138	72	18	comparing	compare	VERB
iajs-2138	72	19	with	with	ADP
iajs-2138	72	20	g1	g1	NOUN
iajs-2138	72	21	and	and	CCONJ
iajs-2138	72	22	g3	g3	NOUN
iajs-2138	72	23	.	.	PUNCT
iajs-2138	73	1	while	while	SCONJ
iajs-2138	73	2	there	there	PRON
iajs-2138	73	3	is	be	VERB
iajs-2138	73	4	significant	significant	ADJ
iajs-2138	73	5	reduction	reduction	NOUN
iajs-2138	73	6	in	in	ADP
iajs-2138	73	7	these	these	DET
iajs-2138	73	8	parameters	parameter	NOUN
iajs-2138	73	9	in	in	ADP
iajs-2138	73	10	g3	g3	PROPN
iajs-2138	73	11	compared	compare	VERB
iajs-2138	73	12	to	to	ADP
iajs-2138	73	13	g1	g1	PROPN
iajs-2138	73	14	and	and	CCONJ
iajs-2138	73	15	g2	g2	PROPN
iajs-2138	73	16	.	.	PUNCT
iajs-2138	74	1	results	result	NOUN
iajs-2138	74	2	revealed	reveal	VERB
iajs-2138	74	3	a	a	DET
iajs-2138	74	4	highly	highly	ADV
iajs-2138	74	5	significant	significant	ADJ
iajs-2138	74	6	decrease	decrease	NOUN
iajs-2138	74	7	in	in	ADP
iajs-2138	74	8	g2	g2	PROPN
iajs-2138	74	9	in	in	ADP
iajs-2138	74	10	tsh	tsh	NOUN
iajs-2138	74	11	levels	level	NOUN
iajs-2138	74	12	comparing	compare	VERB
iajs-2138	74	13	to	to	ADP
iajs-2138	74	14	g1and	g1and	PROPN
iajs-2138	74	15	g3	g3	PROPN
iajs-2138	74	16	.	.	PUNCT
iajs-2138	75	1	in	in	ADP
iajs-2138	75	2	addition	addition	NOUN
iajs-2138	75	3	,	,	PUNCT
iajs-2138	75	4	there	there	PRON
iajs-2138	75	5	are	be	VERB
iajs-2138	75	6	highly	highly	ADV
iajs-2138	75	7	significant	significant	ADJ
iajs-2138	75	8	increase	increase	NOUN
iajs-2138	75	9	in	in	ADP
iajs-2138	75	10	tsh	tsh	ADJ
iajs-2138	75	11	level	level	NOUN
iajs-2138	75	12	in	in	ADP
iajs-2138	75	13	g3	g3	NOUN
iajs-2138	75	14	compared	compare	VERB
iajs-2138	75	15	to	to	ADP
iajs-2138	75	16	g1	g1	PROPN
iajs-2138	75	17	and	and	CCONJ
iajs-2138	75	18	g2	g2	PROPN
iajs-2138	75	19	.	.	PUNCT
iajs-2138	76	1	diabetic	diabetic	ADJ
iajs-2138	76	2	patients	patient	NOUN
iajs-2138	76	3	seem	seem	VERB
iajs-2138	76	4	to	to	PART
iajs-2138	76	5	influence	influence	VERB
iajs-2138	76	6	thyroid	thyroid	NOUN
iajs-2138	76	7	function	function	NOUN
iajs-2138	76	8	in	in	ADP
iajs-2138	76	9	level	level	NOUN
iajs-2138	76	10	of	of	ADP
iajs-2138	76	11	hypothalamic	hypothalamic	ADJ
iajs-2138	76	12	control	control	NOUN
iajs-2138	76	13	of	of	ADP
iajs-2138	76	14	tsh	tsh	NOUN
iajs-2138	76	15	release	release	NOUN
iajs-2138	76	16	and	and	CCONJ
iajs-2138	76	17	at	at	ADP
iajs-2138	76	18	peripheral	peripheral	ADJ
iajs-2138	76	19	tissue	tissue	NOUN
iajs-2138	76	20	by	by	ADP
iajs-2138	76	21	converting	convert	VERB
iajs-2138	76	22	t4	t4	PROPN
iajs-2138	76	23	to	to	ADP
iajs-2138	76	24	t3	t3	PROPN
iajs-2138	76	25	.	.	PUNCT
iajs-2138	77	1	high	high	ADJ
iajs-2138	77	2	levels	level	NOUN
iajs-2138	77	3	of	of	ADP
iajs-2138	77	4	glucose	glucose	NOUN
iajs-2138	77	5	lead	lead	NOUN
iajs-2138	77	6	to	to	PART
iajs-2138	77	7	decrease	decrease	VERB
iajs-2138	77	8	in	in	ADP
iajs-2138	77	9	deiodinase	deiodinase	ADJ
iajs-2138	77	10	enzyme	enzyme	NOUN
iajs-2138	77	11	concentration	concentration	NOUN
iajs-2138	77	12	in	in	ADP
iajs-2138	77	13	liver	liver	NOUN
iajs-2138	77	14	,	,	PUNCT
iajs-2138	77	15	decreased	decrease	VERB
iajs-2138	77	16	concentration	concentration	NOUN
iajs-2138	77	17	of	of	ADP
iajs-2138	77	18	t3	t3	PROPN
iajs-2138	77	19	,	,	PUNCT
iajs-2138	77	20	elevation	elevation	NOUN
iajs-2138	77	21	levels	level	NOUN
iajs-2138	77	22	of	of	ADP
iajs-2138	77	23	reverse	reverse	ADJ
iajs-2138	77	24	t3	t3	NOUN
iajs-2138	77	25	and	and	CCONJ
iajs-2138	77	26	low	low	ADJ
iajs-2138	77	27	,	,	PUNCT
iajs-2138	77	28	normal	normal	ADJ
iajs-2138	77	29	,	,	PUNCT
iajs-2138	77	30	or	or	CCONJ
iajs-2138	77	31	high	high	ADJ
iajs-2138	77	32	level	level	NOUN
iajs-2138	77	33	of	of	ADP
iajs-2138	77	34	t4	t4	PROPN
iajs-2138	77	35	[	[	X
iajs-2138	77	36	17	17	NUM
iajs-2138	77	37	]	]	PUNCT
iajs-2138	77	38	.	.	PUNCT
iajs-2138	78	1	results	result	NOUN
iajs-2138	78	2	in	in	ADP
iajs-2138	78	3	table	table	NOUN
iajs-2138	78	4	1	1	NUM
iajs-2138	78	5	,	,	PUNCT
iajs-2138	78	6	revealed	reveal	VERB
iajs-2138	78	7	a	a	DET
iajs-2138	78	8	highly	highly	ADV
iajs-2138	78	9	significant	significant	ADJ
iajs-2138	78	10	increase	increase	NOUN
iajs-2138	78	11	in	in	ADP
iajs-2138	78	12	chitotriosidase-1	chitotriosidase-1	PROPN
iajs-2138	78	13	levels	level	NOUN
iajs-2138	78	14	in	in	ADP
iajs-2138	78	15	g2	g2	PROPN
iajs-2138	78	16	comparing	compare	VERB
iajs-2138	78	17	to	to	ADP
iajs-2138	78	18	g1and	g1and	PROPN
iajs-2138	78	19	g3	g3	PROPN
iajs-2138	78	20	.	.	PUNCT
iajs-2138	78	21	results	result	NOUN
iajs-2138	78	22	,	,	PUNCT
iajs-2138	78	23	also	also	ADV
iajs-2138	78	24	,	,	PUNCT
iajs-2138	78	25	showed	show	VERB
iajs-2138	78	26	a	a	DET
iajs-2138	78	27	highly	highly	ADV
iajs-2138	78	28	significant	significant	ADJ
iajs-2138	78	29	decrease	decrease	NOUN
iajs-2138	78	30	in	in	ADP
iajs-2138	78	31	g3	g3	PROPN
iajs-2138	78	32	comparing	compare	VERB
iajs-2138	78	33	to	to	ADP
iajs-2138	78	34	g2	g2	PROPN
iajs-2138	78	35	and	and	CCONJ
iajs-2138	78	36	a	a	DET
iajs-2138	78	37	significant	significant	ADJ
iajs-2138	78	38	increase	increase	NOUN
iajs-2138	78	39	was	be	AUX
iajs-2138	78	40	found	find	VERB
iajs-2138	78	41	in	in	ADP
iajs-2138	78	42	g3	g3	NOUN
iajs-2138	78	43	comparing	compare	VERB
iajs-2138	78	44	to	to	ADP
iajs-2138	78	45	g1	g1	VERB
iajs-2138	78	46	.	.	PUNCT
iajs-2138	79	1	54	54	NUM
iajs-2138	79	2	ibn	ibn	PROPN
iajs-2138	79	3	al	al	PROPN
iajs-2138	79	4	-	-	PUNCT
iajs-2138	79	5	haitham	haitham	PROPN
iajs-2138	79	6	jour	jour	X
iajs-2138	79	7	.	.	PROPN
iajs-2138	79	8	for	for	ADP
iajs-2138	79	9	pure	pure	ADJ
iajs-2138	79	10	&	&	CCONJ
iajs-2138	79	11	appl	appl	PROPN
iajs-2138	79	12	.	.	PUNCT
iajs-2138	80	1	sci	sci	PROPN
iajs-2138	80	2	.	.	PROPN
iajs-2138	80	3	32	32	NUM
iajs-2138	80	4	(	(	PUNCT
iajs-2138	80	5	2	2	NUM
iajs-2138	80	6	)	)	SYM
iajs-2138	80	7	2019	2019	NUM
iajs-2138	80	8	activity	activity	NOUN
iajs-2138	80	9	of	of	ADP
iajs-2138	80	10	chitotriosidase-1	chitotriosidase-1	NOUN
iajs-2138	80	11	elevated	elevate	VERB
iajs-2138	80	12	in	in	ADP
iajs-2138	80	13	patients	patient	NOUN
iajs-2138	80	14	with	with	ADP
iajs-2138	80	15	newly	newly	ADV
iajs-2138	80	16	diagnosed	diagnose	VERB
iajs-2138	80	17	,	,	PUNCT
iajs-2138	80	18	untreated	untreated	ADJ
iajs-2138	80	19	,	,	PUNCT
iajs-2138	80	20	and	and	CCONJ
iajs-2138	80	21	uncomplicated	uncomplicated	ADJ
iajs-2138	80	22	type	type	NOUN
iajs-2138	80	23	2	2	NUM
iajs-2138	80	24	dm	dm	NUM
iajs-2138	80	25	which	which	PRON
iajs-2138	80	26	is	be	AUX
iajs-2138	80	27	positively	positively	ADV
iajs-2138	80	28	linked	link	VERB
iajs-2138	80	29	to	to	ADP
iajs-2138	80	30	glucose	glucose	NOUN
iajs-2138	80	31	levels	level	NOUN
iajs-2138	80	32	,	,	PUNCT
iajs-2138	80	33	age	age	NOUN
iajs-2138	80	34	,	,	PUNCT
iajs-2138	80	35	and	and	CCONJ
iajs-2138	80	36	asymmetric	asymmetric	ADJ
iajs-2138	80	37	dimethylarginine	dimethylarginine	ADJ
iajs-2138	80	38	(	(	PUNCT
iajs-2138	80	39	adma	adma	NOUN
iajs-2138	80	40	)	)	PUNCT
iajs-2138	80	41	levels	level	NOUN
iajs-2138	80	42	of	of	ADP
iajs-2138	80	43	those	those	DET
iajs-2138	80	44	patients	patient	NOUN
iajs-2138	80	45	.increased	.increase	VERB
iajs-2138	80	46	adma	adma	PROPN
iajs-2138	80	47	levels	level	NOUN
iajs-2138	80	48	inhibit	inhibit	VERB
iajs-2138	80	49	nitric	nitric	ADJ
iajs-2138	80	50	oxide	oxide	NOUN
iajs-2138	80	51	production	production	NOUN
iajs-2138	80	52	in	in	ADP
iajs-2138	80	53	addition	addition	NOUN
iajs-2138	80	54	to	to	PART
iajs-2138	80	55	impair	impair	VERB
iajs-2138	80	56	endothelial	endothelial	ADJ
iajs-2138	80	57	function	function	NOUN
iajs-2138	80	58	[	[	X
iajs-2138	80	59	18,19	18,19	NUM
iajs-2138	80	60	]	]	PUNCT
iajs-2138	80	61	.	.	PUNCT
iajs-2138	81	1	evidence	evidence	NOUN
iajs-2138	81	2	from	from	ADP
iajs-2138	81	3	experimental	experimental	ADJ
iajs-2138	81	4	studies	study	NOUN
iajs-2138	81	5	illustrated	illustrate	VERB
iajs-2138	81	6	increase	increase	NOUN
iajs-2138	81	7	in	in	ADP
iajs-2138	81	8	chitotriosidase-1	chitotriosidase-1	PROPN
iajs-2138	81	9	levels	level	NOUN
iajs-2138	81	10	in	in	ADP
iajs-2138	81	11	pathological	pathological	ADJ
iajs-2138	81	12	conditions	condition	NOUN
iajs-2138	81	13	,	,	PUNCT
iajs-2138	81	14	like	like	ADP
iajs-2138	81	15	atherosclerosis	atherosclerosis	NOUN
iajs-2138	81	16	,	,	PUNCT
iajs-2138	81	17	coronary	coronary	ADJ
iajs-2138	81	18	artery	artery	NOUN
iajs-2138	81	19	disease	disease	NOUN
iajs-2138	81	20	,	,	PUNCT
iajs-2138	81	21	cerebrovascular	cerebrovascular	ADJ
iajs-2138	81	22	dementia	dementia	NOUN
iajs-2138	81	23	and	and	CCONJ
iajs-2138	81	24	complications	complication	NOUN
iajs-2138	81	25	of	of	ADP
iajs-2138	81	26	dm	dm	PROPN
iajs-2138	81	27	[	[	X
iajs-2138	81	28	20	20	NUM
iajs-2138	81	29	]	]	PUNCT
iajs-2138	81	30	.	.	PUNCT
iajs-2138	82	1	it	it	PRON
iajs-2138	82	2	has	have	AUX
iajs-2138	82	3	been	be	AUX
iajs-2138	82	4	display	display	NOUN
iajs-2138	82	5	that	that	PRON
iajs-2138	82	6	increased	increase	VERB
iajs-2138	82	7	in	in	ADP
iajs-2138	82	8	chitotriosidase-1	chitotriosidase-1	NOUN
iajs-2138	82	9	levels	level	NOUN
iajs-2138	82	10	may	may	AUX
iajs-2138	82	11	be	be	AUX
iajs-2138	82	12	associated	associate	VERB
iajs-2138	82	13	with	with	ADP
iajs-2138	82	14	inflammatory	inflammatory	ADJ
iajs-2138	82	15	status	status	NOUN
iajs-2138	82	16	[	[	X
iajs-2138	82	17	21	21	NUM
iajs-2138	82	18	]	]	PUNCT
iajs-2138	82	19	.	.	PUNCT
iajs-2138	83	1	study	study	PROPN
iajs-2138	83	2	assumed	assume	VERB
iajs-2138	83	3	that	that	SCONJ
iajs-2138	83	4	chitotriosidase-1	chitotriosidase-1	PROPN
iajs-2138	83	5	have	have	VERB
iajs-2138	83	6	role	role	NOUN
iajs-2138	83	7	in	in	ADP
iajs-2138	83	8	the	the	DET
iajs-2138	83	9	development	development	NOUN
iajs-2138	83	10	of	of	ADP
iajs-2138	83	11	atherosclerosis	atherosclerosis	NOUN
iajs-2138	83	12	,	,	PUNCT
iajs-2138	83	13	which	which	PRON
iajs-2138	83	14	forms	form	VERB
iajs-2138	83	15	association	association	NOUN
iajs-2138	83	16	with	with	ADP
iajs-2138	83	17	type	type	NOUN
iajs-2138	83	18	2	2	NUM
iajs-2138	83	19	diabetes	diabetes	NOUN
iajs-2138	83	20	patients	patient	NOUN
iajs-2138	83	21	[	[	X
iajs-2138	83	22	22	22	NUM
iajs-2138	83	23	]	]	PUNCT
iajs-2138	83	24	.	.	PUNCT
iajs-2138	84	1	correlation	correlation	NOUN
iajs-2138	84	2	of	of	ADP
iajs-2138	84	3	chitriosidase-1	chitriosidase-1	PROPN
iajs-2138	84	4	were	be	AUX
iajs-2138	84	5	examined	examine	VERB
iajs-2138	84	6	with	with	ADP
iajs-2138	84	7	the	the	DET
iajs-2138	84	8	other	other	ADJ
iajs-2138	84	9	parameters	parameter	NOUN
iajs-2138	84	10	and	and	CCONJ
iajs-2138	84	11	rcoefficient	rcoefficient	NOUN
iajs-2138	84	12	demonstrate	demonstrate	NOUN
iajs-2138	84	13	in	in	ADP
iajs-2138	84	14	table	table	NOUN
iajs-2138	84	15	2	2	NUM
iajs-2138	84	16	,	,	PUNCT
iajs-2138	84	17	with	with	ADP
iajs-2138	84	18	p	p	NOUN
iajs-2138	84	19	-	-	PUNCT
iajs-2138	84	20	value	value	NOUN
iajs-2138	84	21	.	.	PUNCT
iajs-2138	85	1	table	table	NOUN
iajs-2138	85	2	2	2	NUM
iajs-2138	85	3	.	.	X
iajs-2138	85	4	rcoefficient	rcoefficient	NOUN
iajs-2138	85	5	and	and	CCONJ
iajs-2138	85	6	p	p	NOUN
iajs-2138	85	7	-	-	PUNCT
iajs-2138	85	8	value	value	NOUN
iajs-2138	85	9	of	of	ADP
iajs-2138	85	10	chitriosidase-1	chitriosidase-1	PROPN
iajs-2138	85	11	with	with	ADP
iajs-2138	85	12	tsh	tsh	NOUN
iajs-2138	85	13	,	,	PUNCT
iajs-2138	85	14	t3	t3	PROPN
iajs-2138	85	15	and	and	CCONJ
iajs-2138	85	16	t4	t4	PROPN
iajs-2138	85	17	.	.	PUNCT
iajs-2138	86	1	parameters	parameter	NOUN
iajs-2138	86	2	chitotriosidase-1	chitotriosidase-1	PROPN
iajs-2138	86	3	(	(	PUNCT
iajs-2138	86	4	ng	ng	PROPN
iajs-2138	86	5	/	/	SYM
iajs-2138	86	6	ml	ml	PROPN
iajs-2138	86	7	)	)	PUNCT
iajs-2138	86	8	r1	r1	PROPN
iajs-2138	86	9	t	t	PROPN
iajs-2138	86	10	-	-	PUNCT
iajs-2138	86	11	test	test	NOUN
iajs-2138	86	12	chitotriosidase-1	chitotriosidase-1	PROPN
iajs-2138	86	13	(	(	PUNCT
iajs-2138	86	14	ng	ng	PROPN
iajs-2138	86	15	/	/	SYM
iajs-2138	86	16	ml	ml	PROPN
iajs-2138	86	17	)	)	PUNCT
iajs-2138	86	18	r2	r2	PROPN
iajs-2138	86	19	t	t	PROPN
iajs-2138	86	20	-	-	PUNCT
iajs-2138	86	21	test	test	NOUN
iajs-2138	86	22	chitotriosidase-1	chitotriosidase-1	PROPN
iajs-2138	86	23	(	(	PUNCT
iajs-2138	86	24	ng	ng	PROPN
iajs-2138	86	25	/	/	SYM
iajs-2138	86	26	ml	ml	PROPN
iajs-2138	86	27	)	)	PUNCT
iajs-2138	86	28	r3	r3	PROPN
iajs-2138	86	29	t	t	PROPN
iajs-2138	86	30	-	-	PUNCT
iajs-2138	86	31	test	test	NOUN
iajs-2138	86	32	tsh	tsh	NOUN
iajs-2138	86	33	(	(	PUNCT
iajs-2138	86	34	nmol	nmol	NOUN
iajs-2138	86	35	/	/	SYM
iajs-2138	86	36	l	l	NOUN
iajs-2138	86	37	)	)	PUNCT
iajs-2138	86	38	-0.265	-0.265	PUNCT
iajs-2138	86	39	p≤0.05	p≤0.05	NOUN
iajs-2138	86	40	0.100	0.100	NUM
iajs-2138	86	41	p≤0.05	p≤0.05	NOUN
iajs-2138	86	42	-0.224	-0.224	PUNCT
iajs-2138	86	43	p≤0.05	p≤0.05	NOUN
iajs-2138	86	44	t3	t3	PROPN
iajs-2138	86	45	(	(	PUNCT
iajs-2138	86	46	nmol	nmol	PROPN
iajs-2138	86	47	/	/	SYM
iajs-2138	86	48	l	l	NOUN
iajs-2138	86	49	)	)	PUNCT
iajs-2138	86	50	0.033	0.033	NUM
iajs-2138	86	51	p≤0.05	p≤0.05	NOUN
iajs-2138	86	52	-0.260	-0.260	PUNCT
iajs-2138	86	53	p≤0.05	p≤0.05	NOUN
iajs-2138	86	54	-0.012	-0.012	INTJ
iajs-2138	86	55	p≤0.05	p≤0.05	NOUN
iajs-2138	86	56	t4	t4	PROPN
iajs-2138	86	57	(	(	PUNCT
iajs-2138	86	58	nmol	nmol	PROPN
iajs-2138	86	59	/	/	SYM
iajs-2138	86	60	l	l	NOUN
iajs-2138	86	61	)	)	PUNCT
iajs-2138	86	62	0.218	0.218	NUM
iajs-2138	86	63	p≤0.05	p≤0.05	NOUN
iajs-2138	86	64	-0.167	-0.167	NOUN
iajs-2138	86	65	p≤0.05	p≤0.05	NOUN
iajs-2138	86	66	0.159	0.159	NUM
iajs-2138	86	67	p≤0.05	p≤0.05	NOUN
iajs-2138	86	68	a	a	DET
iajs-2138	86	69	significant	significant	ADJ
iajs-2138	86	70	negative	negative	ADJ
iajs-2138	86	71	correlation	correlation	NOUN
iajs-2138	86	72	was	be	AUX
iajs-2138	86	73	observed	observe	VERB
iajs-2138	86	74	between	between	ADP
iajs-2138	86	75	chitotriosidase-1	chitotriosidase-1	PROPN
iajs-2138	86	76	and	and	CCONJ
iajs-2138	86	77	tsh	tsh	NOUN
iajs-2138	86	78	in	in	ADP
iajs-2138	86	79	g1and	g1and	PROPN
iajs-2138	86	80	g3	g3	PROPN
iajs-2138	86	81	(	(	PUNCT
iajs-2138	86	82	p≤0.05	p≤0.05	NOUN
iajs-2138	86	83	,	,	PUNCT
iajs-2138	86	84	r1=-0.265	r1=-0.265	NOUN
iajs-2138	86	85	,	,	PUNCT
iajs-2138	86	86	r3=	r3=	NOUN
iajs-2138	86	87	-0.224	-0.224	NOUN
iajs-2138	86	88	)	)	PUNCT
iajs-2138	86	89	,	,	PUNCT
iajs-2138	86	90	while	while	SCONJ
iajs-2138	86	91	a	a	DET
iajs-2138	86	92	significant	significant	ADJ
iajs-2138	86	93	positive	positive	ADJ
iajs-2138	86	94	correlation	correlation	NOUN
iajs-2138	86	95	was	be	AUX
iajs-2138	86	96	found	find	VERB
iajs-2138	86	97	in	in	ADP
iajs-2138	86	98	g2	g2	PROPN
iajs-2138	86	99	(	(	PUNCT
iajs-2138	86	100	p≤0.05	p≤0.05	PROPN
iajs-2138	86	101	,	,	PUNCT
iajs-2138	86	102	r2=	r2=	PROPN
iajs-2138	86	103	0.100	0.100	NUM
iajs-2138	86	104	)	)	PUNCT
iajs-2138	86	105	as	as	SCONJ
iajs-2138	86	106	shown	show	VERB
iajs-2138	86	107	in	in	ADP
iajs-2138	86	108	table	table	NOUN
iajs-2138	86	109	2	2	NUM
iajs-2138	86	110	.	.	PUNCT
iajs-2138	86	111	table	table	NOUN
iajs-2138	86	112	2	2	NUM
iajs-2138	86	113	,	,	PUNCT
iajs-2138	86	114	revealed	reveal	VERB
iajs-2138	86	115	a	a	DET
iajs-2138	86	116	significant	significant	ADJ
iajs-2138	86	117	positive	positive	ADJ
iajs-2138	86	118	correlation	correlation	NOUN
iajs-2138	86	119	was	be	AUX
iajs-2138	86	120	found	find	VERB
iajs-2138	86	121	between	between	ADP
iajs-2138	86	122	chitotriosidase-1	chitotriosidase-1	PROPN
iajs-2138	86	123	and	and	CCONJ
iajs-2138	86	124	t3	t3	PROPN
iajs-2138	86	125	in	in	ADP
iajs-2138	86	126	g1	g1	PROPN
iajs-2138	86	127	,	,	PUNCT
iajs-2138	86	128	while	while	SCONJ
iajs-2138	86	129	a	a	DET
iajs-2138	86	130	significant	significant	ADJ
iajs-2138	86	131	negative	negative	ADJ
iajs-2138	86	132	correlation	correlation	NOUN
iajs-2138	86	133	in	in	ADP
iajs-2138	86	134	g2	g2	PROPN
iajs-2138	86	135	and	and	CCONJ
iajs-2138	86	136	g3	g3	PROPN
iajs-2138	86	137	(	(	PUNCT
iajs-2138	86	138	p≤0.05	p≤0.05	NOUN
iajs-2138	86	139	,	,	PUNCT
iajs-2138	86	140	r1=+0.033	r1=+0.033	NOUN
iajs-2138	86	141	,	,	PUNCT
iajs-2138	86	142	r2=0.260	r2=0.260	NUM
iajs-2138	86	143	,	,	PUNCT
iajs-2138	86	144	r3=-0.012	r3=-0.012	NOUN
iajs-2138	86	145	)	)	PUNCT
iajs-2138	86	146	.	.	PUNCT
iajs-2138	87	1	a	a	DET
iajs-2138	87	2	significant	significant	ADJ
iajs-2138	87	3	positive	positive	ADJ
iajs-2138	87	4	correlation	correlation	NOUN
iajs-2138	87	5	was	be	AUX
iajs-2138	87	6	found	find	VERB
iajs-2138	87	7	between	between	ADP
iajs-2138	87	8	chitotriosidase	chitotriosidase	NOUN
iajs-2138	87	9	-1	-1	PUNCT
iajs-2138	87	10	and	and	CCONJ
iajs-2138	87	11	t4	t4	PROPN
iajs-2138	87	12	in	in	ADP
iajs-2138	87	13	g1	g1	PROPN
iajs-2138	87	14	(	(	PUNCT
iajs-2138	87	15	p≤0.05	p≤0.05	NOUN
iajs-2138	87	16	,	,	PUNCT
iajs-2138	87	17	r1=0.218	r1=0.218	NOUN
iajs-2138	87	18	)	)	PUNCT
iajs-2138	87	19	,	,	PUNCT
iajs-2138	87	20	but	but	CCONJ
iajs-2138	87	21	there	there	PRON
iajs-2138	87	22	was	be	VERB
iajs-2138	87	23	a	a	DET
iajs-2138	87	24	significant	significant	ADJ
iajs-2138	87	25	negative	negative	ADJ
iajs-2138	87	26	correlation	correlation	NOUN
iajs-2138	87	27	in	in	ADP
iajs-2138	87	28	g2	g2	PROPN
iajs-2138	87	29	and	and	CCONJ
iajs-2138	87	30	g3	g3	PROPN
iajs-2138	87	31	(	(	PUNCT
iajs-2138	87	32	p≤0.05	p≤0.05	PROPN
iajs-2138	87	33	,	,	PUNCT
iajs-2138	87	34	r2=	r2=	PROPN
iajs-2138	87	35	-0.167	-0.167	ADV
iajs-2138	87	36	,	,	PUNCT
iajs-2138	87	37	r3=	r3=	NOUN
iajs-2138	87	38	0.159	0.159	NUM
iajs-2138	87	39	)	)	PUNCT
iajs-2138	87	40	.	.	PUNCT
iajs-2138	88	1	4	4	X
iajs-2138	88	2	.	.	X
iajs-2138	88	3	conclusion	conclusion	NOUN
iajs-2138	88	4	conclusion	conclusion	NOUN
iajs-2138	88	5	could	could	AUX
iajs-2138	88	6	be	be	AUX
iajs-2138	88	7	drowning	drown	VERB
iajs-2138	88	8	from	from	ADP
iajs-2138	88	9	this	this	DET
iajs-2138	88	10	study	study	NOUN
iajs-2138	88	11	that	that	SCONJ
iajs-2138	88	12	chitotriosidase-1levels	chitotriosidase-1level	NOUN
iajs-2138	88	13	were	be	AUX
iajs-2138	88	14	changed	change	VERB
iajs-2138	88	15	in	in	ADP
iajs-2138	88	16	patients	patient	NOUN
iajs-2138	88	17	’	'	PUNCT
iajs-2138	88	18	groups	group	NOUN
iajs-2138	88	19	that	that	PRON
iajs-2138	88	20	may	may	AUX
iajs-2138	88	21	be	be	AUX
iajs-2138	88	22	used	use	VERB
iajs-2138	88	23	in	in	ADP
iajs-2138	88	24	monitoring	monitoring	NOUN
iajs-2138	88	25	and	and	CCONJ
iajs-2138	88	26	early	early	ADJ
iajs-2138	88	27	diagnosis	diagnosis	NOUN
iajs-2138	88	28	of	of	ADP
iajs-2138	88	29	thyroid	thyroid	NOUN
iajs-2138	88	30	disorder	disorder	NOUN
iajs-2138	88	31	in	in	ADP
iajs-2138	88	32	these	these	DET
iajs-2138	88	33	patients	patient	NOUN
iajs-2138	88	34	depending	depend	VERB
iajs-2138	88	35	on	on	ADP
iajs-2138	88	36	the	the	DET
iajs-2138	88	37	significant	significant	ADJ
iajs-2138	88	38	relation	relation	NOUN
iajs-2138	88	39	for	for	ADP
iajs-2138	88	40	chitotriosidase-1	chitotriosidase-1	PROPN
iajs-2138	88	41	with	with	ADP
iajs-2138	88	42	t3	t3	PROPN
iajs-2138	88	43	,	,	PUNCT
iajs-2138	88	44	t4	t4	PROPN
iajs-2138	88	45	and	and	CCONJ
iajs-2138	88	46	tsh	tsh	PROPN
iajs-2138	88	47	.	.	PUNCT
iajs-2138	88	48	references	reference	NOUN
iajs-2138	88	49	1	1	NUM
iajs-2138	88	50	.	.	PUNCT
iajs-2138	89	1	tomer	tomer	NOUN
iajs-2138	89	2	,	,	PUNCT
iajs-2138	89	3	y.	y.	PROPN
iajs-2138	89	4	;	;	PUNCT
iajs-2138	89	5	dolan	dolan	PROPN
iajs-2138	89	6	,	,	PUNCT
iajs-2138	89	7	l.m	l.m	PROPN
iajs-2138	89	8	.	.	PROPN
iajs-2138	89	9	;	;	PUNCT
iajs-2138	89	10	kahaly	kahaly	PROPN
iajs-2138	89	11	,	,	PUNCT
iajs-2138	89	12	g.	g.	PROPN
iajs-2138	89	13	;	;	PUNCT
iajs-2138	89	14	divers	diver	NOUN
iajs-2138	89	15	,	,	PUNCT
iajs-2138	89	16	j.	j.	PROPN
iajs-2138	89	17	;	;	PUNCT
iajs-2138	89	18	d'agostino	d'agostino	PROPN
iajs-2138	89	19	,	,	PUNCT
iajs-2138	89	20	r.b	r.b	PROPN
iajs-2138	89	21	.	.	PROPN
iajs-2138	89	22	;	;	PUNCT
iajs-2138	89	23	imperatore	imperatore	X
iajs-2138	89	24	,	,	PUNCT
iajs-2138	89	25	g.	g.	PROPN
iajs-2138	89	26	;	;	PUNCT
iajs-2138	89	27	dabelea	dabelea	ADV
iajs-2138	89	28	,	,	PUNCT
iajs-2138	89	29	d.	d.	PROPN
iajs-2138	89	30	;	;	PUNCT
iajs-2138	89	31	marcovina	marcovina	PROPN
iajs-2138	89	32	,	,	PUNCT
iajs-2138	89	33	s.	s.	PROPN
iajs-2138	89	34	;	;	PUNCT
iajs-2138	89	35	black	black	PROPN
iajs-2138	89	36	,	,	PUNCT
iajs-2138	89	37	mh	mh	PROPN
iajs-2138	89	38	.	.	PUNCT
iajs-2138	89	39	;	;	PUNCT
iajs-2138	89	40	pihoker	pihoker	PROPN
iajs-2138	89	41	,	,	PUNCT
iajs-2138	89	42	c.	c.	PROPN
iajs-2138	89	43	;	;	PUNCT
iajs-2138	89	44	hasham	hasham	PROPN
iajs-2138	89	45	,	,	PUNCT
iajs-2138	89	46	a.	a.	NOUN
iajs-2138	89	47	;	;	PUNCT
iajs-2138	89	48	hammerstad	hammerstad	PROPN
iajs-2138	89	49	,	,	PUNCT
iajs-2138	89	50	s.s	s.s	PROPN
iajs-2138	89	51	.	.	PROPN
iajs-2138	89	52	;	;	PUNCT
iajs-2138	89	53	greenberg	greenberg	PROPN
iajs-2138	89	54	,	,	PUNCT
iajs-2138	89	55	d.a	d.a	PROPN
iajs-2138	89	56	.	.	PROPN
iajs-2138	89	57	;	;	PUNCT
iajs-2138	90	1	lotay	lotay	NOUN
iajs-2138	90	2	,	,	PUNCT
iajs-2138	90	3	v.	v.	PROPN
iajs-2138	90	4	;	;	PUNCT
iajs-2138	90	5	zhang	zhang	PROPN
iajs-2138	90	6	,	,	PUNCT
iajs-2138	90	7	w.	w.	PROPN
iajs-2138	90	8	;	;	PUNCT
iajs-2138	90	9	monti	monti	PROPN
iajs-2138	90	10	,	,	PUNCT
iajs-2138	90	11	m.c	m.c	PROPN
iajs-2138	90	12	.	.	PROPN
iajs-2138	90	13	;	;	PUNCT
iajs-2138	90	14	matheis	matheis	X
iajs-2138	90	15	,	,	PUNCT
iajs-2138	90	16	n.	n.	NOUN
iajs-2138	90	17	genome	genome	NOUN
iajs-2138	90	18	wide	wide	ADJ
iajs-2138	90	19	identification	identification	NOUN
iajs-2138	90	20	of	of	ADP
iajs-2138	90	21	new	new	ADJ
iajs-2138	90	22	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc3579558/#r76	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc3579558/#r76	PUNCT
iajs-2138	90	23	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc5016580/#cit0006	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc5016580/#cit0006	X
iajs-2138	90	24	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc5016580/#cit0007	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc5016580/#cit0007	ADJ
iajs-2138	90	25	https://www.ncbi.nlm.nih.gov/pubmed/?term=tomer%20y%5bauthor%5d&cauthor=true&cauthor_uid=25936594	https://www.ncbi.nlm.nih.gov/pubmed/?term=tomer%20y%5bauthor%5d&cauthor=true&cauthor_uid=25936594	PUNCT
iajs-2138	90	26	https://www.ncbi.nlm.nih.gov/pubmed/?term=dolan%20lm%5bauthor%5d&cauthor=true&cauthor_uid=25936594	https://www.ncbi.nlm.nih.gov/pubmed/?term=dolan%20lm%5bauthor%5d&cauthor=true&cauthor_uid=25936594	NOUN
iajs-2138	90	27	https://www.ncbi.nlm.nih.gov/pubmed/?term=kahaly%20g%5bauthor%5d&cauthor=true&cauthor_uid=25936594	https://www.ncbi.nlm.nih.gov/pubmed/?term=kahaly%20g%5bauthor%5d&cauthor=true&cauthor_uid=25936594	X
iajs-2138	90	28	https://www.ncbi.nlm.nih.gov/pubmed/?term=divers%20j%5bauthor%5d&cauthor=true&cauthor_uid=25936594	https://www.ncbi.nlm.nih.gov/pubmed/?term=divers%20j%5bauthor%5d&cauthor=true&cauthor_uid=25936594	X
iajs-2138	90	29	https://www.ncbi.nlm.nih.gov/pubmed/?term=d%27agostino%20rb%20jr%5bauthor%5d&cauthor=true&cauthor_uid=25936594	https://www.ncbi.nlm.nih.gov/pubmed/?term=d%27agostino%20rb%20jr%5bauthor%5d&cauthor=true&cauthor_uid=25936594	NOUN
iajs-2138	90	30	https://www.ncbi.nlm.nih.gov/pubmed/?term=imperatore%20g%5bauthor%5d&cauthor=true&cauthor_uid=25936594	https://www.ncbi.nlm.nih.gov/pubmed/?term=imperatore%20g%5bauthor%5d&cauthor=true&cauthor_uid=25936594	NOUN
iajs-2138	90	31	https://www.ncbi.nlm.nih.gov/pubmed/?term=dabelea%20d%5bauthor%5d&cauthor=true&cauthor_uid=25936594	https://www.ncbi.nlm.nih.gov/pubmed/?term=dabelea%20d%5bauthor%5d&cauthor=true&cauthor_uid=25936594	X
iajs-2138	90	32	https://www.ncbi.nlm.nih.gov/pubmed/?term=dabelea%20d%5bauthor%5d&cauthor=true&cauthor_uid=25936594	https://www.ncbi.nlm.nih.gov/pubmed/?term=dabelea%20d%5bauthor%5d&cauthor=true&cauthor_uid=25936594	PROPN
iajs-2138	90	33	https://www.ncbi.nlm.nih.gov/pubmed/?term=marcovina%20s%5bauthor%5d&cauthor=true&cauthor_uid=25936594	https://www.ncbi.nlm.nih.gov/pubmed/?term=marcovina%20s%5bauthor%5d&cauthor=true&cauthor_uid=25936594	VERB
iajs-2138	90	34	https://www.ncbi.nlm.nih.gov/pubmed/?term=black%20mh%5bauthor%5d&cauthor=true&cauthor_uid=25936594	https://www.ncbi.nlm.nih.gov/pubmed/?term=black%20mh%5bauthor%5d&cauthor=true&cauthor_uid=25936594	PRON
iajs-2138	90	35	https://www.ncbi.nlm.nih.gov/pubmed/?term=pihoker%20c%5bauthor%5d&cauthor=true&cauthor_uid=25936594	https://www.ncbi.nlm.nih.gov/pubmed/?term=pihoker%20c%5bauthor%5d&cauthor=true&cauthor_uid=25936594	PROPN
iajs-2138	90	36	https://www.ncbi.nlm.nih.gov/pubmed/?term=hasham%20a%5bauthor%5d&cauthor=true&cauthor_uid=25936594	https://www.ncbi.nlm.nih.gov/pubmed/?term=hasham%20a%5bauthor%5d&cauthor=true&cauthor_uid=25936594	PROPN
iajs-2138	90	37	https://www.ncbi.nlm.nih.gov/pubmed/?term=hammerstad%20ss%5bauthor%5d&cauthor=true&cauthor_uid=25936594	https://www.ncbi.nlm.nih.gov/pubmed/?term=hammerstad%20ss%5bauthor%5d&cauthor=true&cauthor_uid=25936594	NOUN
iajs-2138	90	38	https://www.ncbi.nlm.nih.gov/pubmed/?term=greenberg%20da%5bauthor%5d&cauthor=true&cauthor_uid=25936594	https://www.ncbi.nlm.nih.gov/pubmed/?term=greenberg%20da%5bauthor%5d&cauthor=true&cauthor_uid=25936594	PROPN
iajs-2138	90	39	https://www.ncbi.nlm.nih.gov/pubmed/?term=greenberg%20da%5bauthor%5d&cauthor=true&cauthor_uid=25936594	https://www.ncbi.nlm.nih.gov/pubmed/?term=greenberg%20da%5bauthor%5d&cauthor=true&cauthor_uid=25936594	NOUN
iajs-2138	90	40	https://www.ncbi.nlm.nih.gov/pubmed/?term=lotay%20v%5bauthor%5d&cauthor=true&cauthor_uid=25936594	https://www.ncbi.nlm.nih.gov/pubmed/?term=lotay%20v%5bauthor%5d&cauthor=true&cauthor_uid=25936594	X
iajs-2138	90	41	https://www.ncbi.nlm.nih.gov/pubmed/?term=zhang%20w%5bauthor%5d&cauthor=true&cauthor_uid=25936594	https://www.ncbi.nlm.nih.gov/pubmed/?term=zhang%20w%5bauthor%5d&cauthor=true&cauthor_uid=25936594	PROPN
iajs-2138	90	42	https://www.ncbi.nlm.nih.gov/pubmed/?term=monti%20mc%5bauthor%5d&cauthor=true&cauthor_uid=25936594	https://www.ncbi.nlm.nih.gov/pubmed/?term=monti%20mc%5bauthor%5d&cauthor=true&cauthor_uid=25936594	NOUN
iajs-2138	90	43	https://www.ncbi.nlm.nih.gov/pubmed/?term=matheis%20n%5bauthor%5d&cauthor=true&cauthor_uid=25936594	https://www.ncbi.nlm.nih.gov/pubmed/?term=matheis%20n%5bauthor%5d&cauthor=true&cauthor_uid=25936594	PROPN
iajs-2138	90	44	54	54	NUM
iajs-2138	90	45	ibn	ibn	PROPN
iajs-2138	90	46	al	al	PROPN
iajs-2138	90	47	-	-	PUNCT
iajs-2138	90	48	haitham	haitham	PROPN
iajs-2138	90	49	jour	jour	X
iajs-2138	90	50	.	.	PROPN
iajs-2138	90	51	for	for	ADP
iajs-2138	90	52	pure	pure	ADJ
iajs-2138	90	53	&	&	CCONJ
iajs-2138	90	54	appl	appl	PROPN
iajs-2138	90	55	.	.	PUNCT
iajs-2138	91	1	sci	sci	PROPN
iajs-2138	91	2	.	.	PROPN
iajs-2138	91	3	32	32	NUM
iajs-2138	91	4	(	(	PUNCT
iajs-2138	91	5	2	2	NUM
iajs-2138	91	6	)	)	SYM
iajs-2138	91	7	2019	2019	NUM
iajs-2138	91	8	genes	gene	NOUN
iajs-2138	91	9	and	and	CCONJ
iajs-2138	91	10	pathways	pathway	NOUN
iajs-2138	91	11	in	in	ADP
iajs-2138	91	12	patients	patient	NOUN
iajs-2138	91	13	with	with	ADP
iajs-2138	91	14	both	both	DET
iajs-2138	91	15	autoimmune	autoimmune	ADJ
iajs-2138	91	16	thyroiditis	thyroiditis	NOUN
iajs-2138	91	17	and	and	CCONJ
iajs-2138	91	18	type	type	NOUN
iajs-2138	91	19	1	1	NUM
iajs-2138	91	20	diabetes	diabetes	NOUN
iajs-2138	91	21	,	,	PUNCT
iajs-2138	91	22	journal	journal	NOUN
iajs-2138	91	23	of	of	ADP
iajs-2138	91	24	autoimmunity	autoimmunity	NOUN
iajs-2138	91	25	.	.	PUNCT
iajs-2138	92	1	2015	2015	NUM
iajs-2138	92	2	,	,	PUNCT
iajs-2138	92	3	60	60	NUM
iajs-2138	92	4	,	,	PUNCT
iajs-2138	92	5	32–39	32–39	NUM
iajs-2138	92	6	.	.	PUNCT
iajs-2138	93	1	2	2	NUM
iajs-2138	93	2	.	.	X
iajs-2138	93	3	fleiner	fleiner	PROPN
iajs-2138	93	4	,	,	PUNCT
iajs-2138	93	5	h.f	h.f	PROPN
iajs-2138	93	6	.	.	PROPN
iajs-2138	93	7	;	;	PUNCT
iajs-2138	93	8	bjøro	bjøro	NOUN
iajs-2138	93	9	,	,	PUNCT
iajs-2138	93	10	t.	t.	PROPN
iajs-2138	93	11	;	;	PUNCT
iajs-2138	94	1	midthjell	midthjell	PROPN
iajs-2138	94	2	,	,	PUNCT
iajs-2138	94	3	k.	k.	PROPN
iajs-2138	94	4	;	;	PUNCT
iajs-2138	94	5	grill	grill	NOUN
iajs-2138	94	6	,	,	PUNCT
iajs-2138	94	7	v.	v.	ADV
iajs-2138	94	8	;	;	PUNCT
iajs-2138	94	9	åsvold	åsvold	ADJ
iajs-2138	94	10	,	,	PUNCT
iajs-2138	94	11	b.o	b.o	PROPN
iajs-2138	94	12	.	.	PROPN
iajs-2138	94	13	prevalence	prevalence	NOUN
iajs-2138	94	14	of	of	ADP
iajs-2138	94	15	thyroid	thyroid	NOUN
iajs-2138	94	16	dysfunction	dysfunction	NOUN
iajs-2138	94	17	in	in	ADP
iajs-2138	94	18	autoimmune	autoimmune	ADJ
iajs-2138	94	19	and	and	CCONJ
iajs-2138	94	20	type	type	NOUN
iajs-2138	94	21	2	2	NUM
iajs-2138	94	22	diabetes	diabete	NOUN
iajs-2138	94	23	:	:	PUNCT
iajs-2138	94	24	the	the	DET
iajs-2138	94	25	population	population	NOUN
iajs-2138	94	26	-	-	PUNCT
iajs-2138	94	27	based	base	VERB
iajs-2138	94	28	hunt	hunt	NOUN
iajs-2138	94	29	study	study	NOUN
iajs-2138	94	30	in	in	ADP
iajs-2138	94	31	norway	norway	PROPN
iajs-2138	94	32	,	,	PUNCT
iajs-2138	94	33	the	the	DET
iajs-2138	94	34	journal	journal	NOUN
iajs-2138	94	35	of	of	ADP
iajs-2138	94	36	clinical	clinical	ADJ
iajs-2138	94	37	endocrinal	endocrinal	ADJ
iajs-2138	94	38	metabolism	metabolism	NOUN
iajs-2138	94	39	.	.	PUNCT
iajs-2138	95	1	2016	2016	NUM
iajs-2138	95	2	,	,	PUNCT
iajs-2138	95	3	101	101	NUM
iajs-2138	95	4	,	,	PUNCT
iajs-2138	95	5	669	669	NUM
iajs-2138	95	6	-	-	SYM
iajs-2138	95	7	677	677	NUM
iajs-2138	95	8	.	.	PUNCT
iajs-2138	96	1	3	3	X
iajs-2138	96	2	.	.	X
iajs-2138	96	3	wang	wang	PROPN
iajs-2138	96	4	,	,	PUNCT
iajs-2138	96	5	c.	c.	PROPN
iajs-2138	96	6	the	the	DET
iajs-2138	96	7	relationship	relationship	NOUN
iajs-2138	96	8	between	between	ADP
iajs-2138	96	9	type	type	NOUN
iajs-2138	96	10	2	2	NUM
iajs-2138	96	11	diabetes	diabetes	NOUN
iajs-2138	96	12	mellitus	mellitus	NOUN
iajs-2138	96	13	and	and	CCONJ
iajs-2138	96	14	related	related	ADJ
iajs-2138	96	15	thyroid	thyroid	NOUN
iajs-2138	96	16	diseases	disease	NOUN
iajs-2138	96	17	,	,	PUNCT
iajs-2138	96	18	journal	journal	NOUN
iajs-2138	96	19	of	of	ADP
iajs-2138	96	20	diabetes	diabetes	NOUN
iajs-2138	96	21	research	research	NOUN
iajs-2138	96	22	.	.	PUNCT
iajs-2138	97	1	2013	2013	NUM
iajs-2138	97	2	,	,	PUNCT
iajs-2138	97	3	13	13	NUM
iajs-2138	97	4	,	,	PUNCT
iajs-2138	97	5	2	2	NUM
iajs-2138	97	6	-	-	SYM
iajs-2138	97	7	3	3	NUM
iajs-2138	97	8	.	.	NOUN
iajs-2138	97	9	4	4	NUM
iajs-2138	97	10	.	.	X
iajs-2138	98	1	collet	collet	NOUN
iajs-2138	98	2	,	,	PUNCT
iajs-2138	98	3	t.h	t.h	PROPN
iajs-2138	98	4	.	.	PROPN
iajs-2138	98	5	;	;	PUNCT
iajs-2138	98	6	gussekloo	gussekloo	PROPN
iajs-2138	98	7	,	,	PUNCT
iajs-2138	98	8	j.	j.	PROPN
iajs-2138	98	9	;	;	PUNCT
iajs-2138	98	10	bauer	bauer	PROPN
iajs-2138	98	11	,	,	PUNCT
iajs-2138	98	12	d.c	d.c	PROPN
iajs-2138	98	13	.	.	PROPN
iajs-2138	98	14	;	;	PUNCT
iajs-2138	98	15	den	den	PROPN
iajs-2138	98	16	elzen	elzen	PROPN
iajs-2138	98	17	,	,	PUNCT
iajs-2138	98	18	w.p	w.p	PROPN
iajs-2138	98	19	.	.	PROPN
iajs-2138	98	20	;	;	PUNCT
iajs-2138	98	21	cappola	cappola	PROPN
iajs-2138	98	22	,	,	PUNCT
iajs-2138	98	23	a.r	a.r	PROPN
iajs-2138	98	24	.	.	PROPN
iajs-2138	98	25	;	;	PUNCT
iajs-2138	98	26	balmer	balmer	PROPN
iajs-2138	98	27	,	,	PUNCT
iajs-2138	98	28	p.	p.	NOUN
iajs-2138	98	29	;	;	PUNCT
iajs-2138	98	30	iervasi	iervasi	PROPN
iajs-2138	98	31	,	,	PUNCT
iajs-2138	98	32	g.	g.	PROPN
iajs-2138	98	33	;	;	PUNCT
iajs-2138	98	34	åsvold	åsvold	ADJ
iajs-2138	98	35	,	,	PUNCT
iajs-2138	98	36	b.o	b.o	PROPN
iajs-2138	98	37	.	.	PROPN
iajs-2138	98	38	;	;	PUNCT
iajs-2138	98	39	sgarbi	sgarbi	PROPN
iajs-2138	98	40	,	,	PUNCT
iajs-2138	98	41	j.a	j.a	PROPN
iajs-2138	98	42	.	.	PROPN
iajs-2138	98	43	;	;	PUNCT
iajs-2138	98	44	völzke	völzke	PROPN
iajs-2138	98	45	,	,	PUNCT
iajs-2138	98	46	h.	h.	PROPN
iajs-2138	98	47	;	;	PUNCT
iajs-2138	98	48	gencer	gencer	NOUN
iajs-2138	98	49	,	,	PUNCT
iajs-2138	98	50	b.	b.	PROPN
iajs-2138	98	51	subclinical	subclinical	ADJ
iajs-2138	98	52	hyperthyroidism	hyperthyroidism	NOUN
iajs-2138	98	53	and	and	CCONJ
iajs-2138	98	54	the	the	DET
iajs-2138	98	55	risk	risk	NOUN
iajs-2138	98	56	of	of	ADP
iajs-2138	98	57	coronary	coronary	ADJ
iajs-2138	98	58	heart	heart	NOUN
iajs-2138	98	59	disease	disease	NOUN
iajs-2138	98	60	and	and	CCONJ
iajs-2138	98	61	mortality	mortality	NOUN
iajs-2138	98	62	.	.	PUNCT
iajs-2138	99	1	archives	archive	NOUN
iajs-2138	99	2	of	of	ADP
iajs-2138	99	3	internal	internal	ADJ
iajs-2138	99	4	medicine	medicine	NOUN
iajs-2138	99	5	.	.	PUNCT
iajs-2138	100	1	2012	2012	NUM
iajs-2138	100	2	,	,	PUNCT
iajs-2138	100	3	172	172	NUM
iajs-2138	100	4	,	,	PUNCT
iajs-2138	100	5	799	799	NUM
iajs-2138	100	6	-	-	SYM
iajs-2138	100	7	809	809	NUM
iajs-2138	100	8	.	.	PUNCT
iajs-2138	101	1	5	5	NUM
iajs-2138	101	2	.	.	X
iajs-2138	101	3	van	van	PROPN
iajs-2138	101	4	aalten	aalten	NOUN
iajs-2138	101	5	,	,	PUNCT
iajs-2138	101	6	d.m	d.m	PROPN
iajs-2138	101	7	.	.	PROPN
iajs-2138	101	8	;	;	PUNCT
iajs-2138	101	9	synstad	synstad	PROPN
iajs-2138	101	10	,	,	PUNCT
iajs-2138	101	11	b.	b.	PROPN
iajs-2138	101	12	;	;	PUNCT
iajs-2138	101	13	brurberg	brurberg	PROPN
iajs-2138	101	14	,	,	PUNCT
iajs-2138	101	15	m.b	m.b	PROPN
iajs-2138	101	16	.	.	PROPN
iajs-2138	101	17	;	;	PUNCT
iajs-2138	102	1	hough	hough	PROPN
iajs-2138	102	2	,	,	PUNCT
iajs-2138	102	3	e.	e.	PROPN
iajs-2138	102	4	;	;	PUNCT
iajs-2138	102	5	riise	riise	PROPN
iajs-2138	102	6	,	,	PUNCT
iajs-2138	102	7	b.w	b.w	PROPN
iajs-2138	102	8	.	.	PROPN
iajs-2138	102	9	;	;	PUNCT
iajs-2138	102	10	eijsink	eijsink	VERB
iajs-2138	102	11	,	,	PUNCT
iajs-2138	102	12	v.g	v.g	PROPN
iajs-2138	102	13	.	.	PROPN
iajs-2138	102	14	;	;	PUNCT
iajs-2138	102	15	wierenga	wierenga	PROPN
iajs-2138	102	16	,	,	PUNCT
iajs-2138	102	17	r.k	r.k	PROPN
iajs-2138	102	18	.	.	PROPN
iajs-2138	102	19	structure	structure	NOUN
iajs-2138	102	20	of	of	ADP
iajs-2138	102	21	a	a	DET
iajs-2138	102	22	two	two	NUM
iajs-2138	102	23	-	-	PUNCT
iajs-2138	102	24	domain	domain	NOUN
iajs-2138	102	25	chitotriosidase	chitotriosidase	NOUN
iajs-2138	102	26	from	from	ADP
iajs-2138	102	27	serratia	serratia	PROPN
iajs-2138	102	28	marcescens	marcescen	NOUN
iajs-2138	102	29	at	at	ADP
iajs-2138	102	30	1.9	1.9	NUM
iajs-2138	102	31	-	-	PUNCT
iajs-2138	102	32	å	å	NOUN
iajs-2138	102	33	resolution	resolution	NOUN
iajs-2138	102	34	.	.	PUNCT
iajs-2138	103	1	proceeding	proceeding	NOUN
iajs-2138	103	2	of	of	ADP
iajs-2138	103	3	the	the	DET
iajs-2138	103	4	national	national	NOUN
iajs-2138	103	5	of	of	ADP
iajs-2138	103	6	sciences	science	NOUN
iajs-2138	103	7	of	of	ADP
iajs-2138	103	8	the	the	DET
iajs-2138	103	9	usa	usa	PROPN
iajs-2138	103	10	.	.	PROPN
iajs-2138	103	11	2000	2000	NUM
iajs-2138	103	12	,	,	PUNCT
iajs-2138	103	13	97	97	NUM
iajs-2138	103	14	,	,	PUNCT
iajs-2138	103	15	58425847	58425847	NUM
iajs-2138	103	16	.	.	PUNCT
iajs-2138	104	1	6	6	NUM
iajs-2138	104	2	.	.	X
iajs-2138	104	3	koch	koch	PROPN
iajs-2138	104	4	,	,	PUNCT
iajs-2138	104	5	be	be	AUX
iajs-2138	104	6	.	.	PUNCT
iajs-2138	104	7	;	;	PUNCT
iajs-2138	105	1	stougaard	stougaard	PROPN
iajs-2138	105	2	,	,	PUNCT
iajs-2138	105	3	j.	j.	PROPN
iajs-2138	105	4	;	;	PUNCT
iajs-2138	105	5	spaink	spaink	PROPN
iajs-2138	105	6	,	,	PUNCT
iajs-2138	105	7	hp	hp	PROPN
iajs-2138	105	8	.	.	PUNCT
iajs-2138	105	9	keeping	keep	VERB
iajs-2138	105	10	track	track	NOUN
iajs-2138	105	11	of	of	ADP
iajs-2138	105	12	the	the	DET
iajs-2138	105	13	growing	grow	VERB
iajs-2138	105	14	number	number	NOUN
iajs-2138	105	15	of	of	ADP
iajs-2138	105	16	biological	biological	ADJ
iajs-2138	105	17	functions	function	NOUN
iajs-2138	105	18	of	of	ADP
iajs-2138	105	19	chitin	chitin	NOUN
iajs-2138	105	20	and	and	CCONJ
iajs-2138	105	21	its	its	PRON
iajs-2138	105	22	interaction	interaction	NOUN
iajs-2138	105	23	partners	partner	NOUN
iajs-2138	105	24	in	in	ADP
iajs-2138	105	25	biomedical	biomedical	ADJ
iajs-2138	105	26	research	research	NOUN
iajs-2138	105	27	,	,	PUNCT
iajs-2138	105	28	glycobiology.2015	glycobiology.2015	PROPN
iajs-2138	105	29	,	,	PUNCT
iajs-2138	105	30	25,469482	25,469482	NUM
iajs-2138	105	31	.	.	PUNCT
iajs-2138	106	1	7	7	X
iajs-2138	106	2	.	.	X
iajs-2138	106	3	bueter	bueter	PROPN
iajs-2138	106	4	,	,	PUNCT
iajs-2138	106	5	c.l	c.l	PROPN
iajs-2138	106	6	.	.	PROPN
iajs-2138	106	7	;	;	PUNCT
iajs-2138	106	8	specht	specht	PROPN
iajs-2138	106	9	,	,	PUNCT
iajs-2138	106	10	c.a	c.a	PROPN
iajs-2138	106	11	.	.	PROPN
iajs-2138	106	12	;	;	PUNCT
iajs-2138	106	13	levitz	levitz	PROPN
iajs-2138	106	14	,	,	PUNCT
iajs-2138	106	15	s.m	s.m	PROPN
iajs-2138	106	16	.	.	PROPN
iajs-2138	106	17	innate	innate	ADJ
iajs-2138	106	18	sensing	sensing	NOUN
iajs-2138	106	19	of	of	ADP
iajs-2138	106	20	chitin	chitin	NOUN
iajs-2138	106	21	and	and	CCONJ
iajs-2138	106	22	chitosan	chitosan	NOUN
iajs-2138	106	23	.	.	PUNCT
iajs-2138	107	1	plos	plos	PROPN
iajs-2138	107	2	pathogens	pathogen	NOUN
iajs-2138	107	3	.	.	PUNCT
iajs-2138	108	1	2013	2013	NUM
iajs-2138	108	2	,	,	PUNCT
iajs-2138	108	3	9	9	NUM
iajs-2138	108	4	,	,	PUNCT
iajs-2138	108	5	1	1	NUM
iajs-2138	108	6	-	-	SYM
iajs-2138	108	7	4	4	NUM
iajs-2138	108	8	.	.	NOUN
iajs-2138	108	9	8	8	NUM
iajs-2138	108	10	.	.	PUNCT
iajs-2138	109	1	stockinger	stockinger	NOUN
iajs-2138	109	2	,	,	PUNCT
iajs-2138	109	3	l.w	l.w	PROPN
iajs-2138	109	4	.	.	PROPN
iajs-2138	109	5	;	;	PUNCT
iajs-2138	109	6	eide	eide	PROPN
iajs-2138	109	7	,	,	PUNCT
iajs-2138	109	8	k.b	k.b	PROPN
iajs-2138	109	9	.	.	PROPN
iajs-2138	109	10	;	;	PUNCT
iajs-2138	109	11	dybvik	dybvik	PROPN
iajs-2138	109	12	,	,	PUNCT
iajs-2138	109	13	a.i	a.i	PROPN
iajs-2138	109	14	.	.	PROPN
iajs-2138	109	15	;	;	PUNCT
iajs-2138	109	16	sletta	sletta	PROPN
iajs-2138	109	17	,	,	PUNCT
iajs-2138	109	18	h.	h.	PROPN
iajs-2138	109	19	;	;	PUNCT
iajs-2138	109	20	vårum	vårum	PROPN
iajs-2138	109	21	,	,	PUNCT
iajs-2138	109	22	k.m	k.m	PROPN
iajs-2138	109	23	.	.	PROPN
iajs-2138	109	24	;	;	PUNCT
iajs-2138	109	25	eijsink	eijsink	VERB
iajs-2138	109	26	,	,	PUNCT
iajs-2138	109	27	v.g	v.g	PROPN
iajs-2138	109	28	.	.	PROPN
iajs-2138	109	29	;	;	PUNCT
iajs-2138	109	30	tøndervik	tøndervik	PROPN
iajs-2138	109	31	,	,	PUNCT
iajs-2138	109	32	a.	a.	NOUN
iajs-2138	109	33	;	;	PUNCT
iajs-2138	109	34	sørlie	sørlie	ADJ
iajs-2138	109	35	,	,	PUNCT
iajs-2138	109	36	m.	m.	NOUN
iajs-2138	109	37	the	the	DET
iajs-2138	109	38	effect	effect	NOUN
iajs-2138	109	39	of	of	ADP
iajs-2138	109	40	the	the	DET
iajs-2138	109	41	carbohydrate	carbohydrate	NOUN
iajs-2138	109	42	binding	bind	VERB
iajs-2138	109	43	module	module	NOUN
iajs-2138	109	44	on	on	ADP
iajs-2138	109	45	substrate	substrate	NOUN
iajs-2138	109	46	degradation	degradation	NOUN
iajs-2138	109	47	by	by	ADP
iajs-2138	109	48	the	the	DET
iajs-2138	109	49	human	human	ADJ
iajs-2138	109	50	chitotriosidase	chitotriosidase	NOUN
iajs-2138	109	51	,	,	PUNCT
iajs-2138	109	52	biochimica	biochimica	PROPN
iajs-2138	109	53	et	et	PROPN
iajs-2138	109	54	biophysica	biophysica	PROPN
iajs-2138	109	55	acta	acta	PROPN
iajs-2138	109	56	(	(	PUNCT
iajs-2138	109	57	bba)proteins	bba)protein	NOUN
iajs-2138	109	58	and	and	CCONJ
iajs-2138	109	59	proteomics	proteomic	NOUN
iajs-2138	109	60	.	.	PUNCT
iajs-2138	110	1	2015	2015	NUM
iajs-2138	110	2	,	,	PUNCT
iajs-2138	110	3	10	10	NUM
iajs-2138	110	4	,	,	PUNCT
iajs-2138	110	5	1494–1501	1494–1501	NUM
iajs-2138	110	6	.	.	NOUN
iajs-2138	111	1	9	9	NUM
iajs-2138	111	2	.	.	X
iajs-2138	111	3	fadel	fadel	PROPN
iajs-2138	111	4	,	,	PUNCT
iajs-2138	111	5	f.	f.	PROPN
iajs-2138	111	6	;	;	PUNCT
iajs-2138	111	7	zhao	zhao	PROPN
iajs-2138	111	8	,	,	PUNCT
iajs-2138	111	9	y.	y.	PROPN
iajs-2138	111	10	;	;	PUNCT
iajs-2138	111	11	cachau	cachau	PROPN
iajs-2138	111	12	,	,	PUNCT
iajs-2138	111	13	r.	r.	PROPN
iajs-2138	111	14	new	new	ADJ
iajs-2138	111	15	insights	insight	NOUN
iajs-2138	111	16	into	into	ADP
iajs-2138	111	17	the	the	DET
iajs-2138	111	18	enzymatic	enzymatic	ADJ
iajs-2138	111	19	mechanism	mechanism	NOUN
iajs-2138	111	20	of	of	ADP
iajs-2138	111	21	human	human	ADJ
iajs-2138	111	22	chitotriosidase	chitotriosidase	NOUN
iajs-2138	111	23	(	(	PUNCT
iajs-2138	111	24	chit1	chit1	NOUN
iajs-2138	111	25	)	)	PUNCT
iajs-2138	111	26	catalytic	catalytic	ADJ
iajs-2138	111	27	domain	domain	NOUN
iajs-2138	111	28	by	by	ADP
iajs-2138	111	29	atomic	atomic	ADJ
iajs-2138	111	30	resolution	resolution	NOUN
iajs-2138	111	31	x	x	NOUN
iajs-2138	111	32	-	-	NOUN
iajs-2138	111	33	ray	ray	NOUN
iajs-2138	111	34	diffraction	diffraction	NOUN
iajs-2138	111	35	and	and	CCONJ
iajs-2138	111	36	hybrid	hybrid	NOUN
iajs-2138	111	37	qm	qm	PROPN
iajs-2138	111	38	/	/	SYM
iajs-2138	111	39	mm	mm	PROPN
iajs-2138	111	40	,	,	PUNCT
iajs-2138	111	41	acta	acta	PROPN
iajs-2138	111	42	crystallographica	crystallographica	PROPN
iajs-2138	111	43	section	section	PROPN
iajs-2138	111	44	d.	d.	PROPN
iajs-2138	111	45	biological	biological	PROPN
iajs-2138	111	46	crystallography.2015	crystallography.2015	PROPN
iajs-2138	111	47	,	,	PUNCT
iajs-2138	111	48	71	71	NUM
iajs-2138	111	49	,	,	PUNCT
iajs-2138	111	50	1455–1470	1455–1470	NUM
iajs-2138	111	51	.	.	PUNCT
iajs-2138	111	52	10	10	NUM
iajs-2138	111	53	.	.	X
iajs-2138	111	54	eide	eide	PROPN
iajs-2138	111	55	,	,	PUNCT
iajs-2138	111	56	k.	k.	PROPN
iajs-2138	111	57	;	;	PUNCT
iajs-2138	111	58	lindbom	lindbom	PROPN
iajs-2138	111	59	,	,	PUNCT
iajs-2138	111	60	r.	r.	PROPN
iajs-2138	111	61	;	;	PUNCT
iajs-2138	111	62	eijsink	eijsink	VERB
iajs-2138	111	63	,	,	PUNCT
iajs-2138	111	64	v.	v.	PROPN
iajs-2138	111	65	;	;	PUNCT
iajs-2138	111	66	norberg	norberg	PROPN
iajs-2138	111	67	,	,	PUNCT
iajs-2138	111	68	m.	m.	NOUN
iajs-2138	111	69	analysis	analysis	NOUN
iajs-2138	111	70	of	of	ADP
iajs-2138	111	71	productive	productive	ADJ
iajs-2138	111	72	binding	bind	VERB
iajs-2138	111	73	modes	mode	NOUN
iajs-2138	111	74	in	in	ADP
iajs-2138	111	75	the	the	DET
iajs-2138	111	76	human	human	ADJ
iajs-2138	111	77	chitotriosidase	chitotriosidase	NOUN
iajs-2138	111	78	,	,	PUNCT
iajs-2138	111	79	febs	febs	NOUN
iajs-2138	111	80	letters	letter	NOUN
iajs-2138	111	81	.	.	PUNCT
iajs-2138	112	1	2013	2013	NUM
iajs-2138	112	2	,	,	PUNCT
iajs-2138	112	3	587	587	NUM
iajs-2138	112	4	,	,	PUNCT
iajs-2138	112	5	3508–3513	3508–3513	NUM
iajs-2138	112	6	.	.	PUNCT
iajs-2138	113	1	11	11	NUM
iajs-2138	113	2	.	.	X
iajs-2138	114	1	malaguarnera	malaguarnera	NOUN
iajs-2138	114	2	,	,	PUNCT
iajs-2138	114	3	l.	l.	PROPN
iajs-2138	114	4	chitotriosidase	chitotriosidase	PROPN
iajs-2138	114	5	:	:	PUNCT
iajs-2138	114	6	the	the	DET
iajs-2138	114	7	yin	yin	PROPN
iajs-2138	114	8	and	and	CCONJ
iajs-2138	114	9	yang	yang	PROPN
iajs-2138	114	10	cellular	cellular	PROPN
iajs-2138	114	11	and	and	CCONJ
iajs-2138	114	12	molecular	molecular	ADJ
iajs-2138	114	13	life	life	NOUN
iajs-2138	114	14	sciences	science	NOUN
iajs-2138	114	15	cmls	cmls	NOUN
iajs-2138	114	16	.	.	PUNCT
iajs-2138	115	1	2006	2006	NUM
iajs-2138	115	2	,	,	PUNCT
iajs-2138	115	3	63	63	NUM
iajs-2138	115	4	,	,	PUNCT
iajs-2138	115	5	3018–3029	3018–3029	NUM
iajs-2138	115	6	.	.	PUNCT
iajs-2138	116	1	12	12	NUM
iajs-2138	116	2	.	.	PUNCT
iajs-2138	117	1	manasa	manasa	PROPN
iajs-2138	117	2	,	,	PUNCT
iajs-2138	117	3	k.	k.	PROPN
iajs-2138	117	4	;	;	PUNCT
iajs-2138	117	5	alan	alan	PROPN
iajs-2138	117	6	,	,	PUNCT
iajs-2138	117	7	k.	k.	PROPN
iajs-2138	117	8	;	;	PUNCT
iajs-2138	117	9	emiko	emiko	PROPN
iajs-2138	117	10	,	,	PUNCT
iajs-2138	117	11	m.	m.	NOUN
iajs-2138	117	12	role	role	NOUN
iajs-2138	117	13	of	of	ADP
iajs-2138	117	14	chitotriosidase	chitotriosidase	NOUN
iajs-2138	117	15	(	(	PUNCT
iajs-2138	117	16	chitinase	chitinase	NOUN
iajs-2138	117	17	1	1	NUM
iajs-2138	117	18	)	)	PUNCT
iajs-2138	117	19	under	under	ADP
iajs-2138	117	20	normal	normal	ADJ
iajs-2138	117	21	and	and	CCONJ
iajs-2138	117	22	disease	disease	NOUN
iajs-2138	117	23	conditions	condition	NOUN
iajs-2138	117	24	.	.	PUNCT
iajs-2138	118	1	journal	journal	NOUN
iajs-2138	118	2	of	of	ADP
iajs-2138	118	3	epithelial	epithelial	ADJ
iajs-2138	118	4	biology	biology	NOUN
iajs-2138	118	5	&	&	CCONJ
iajs-2138	118	6	pharmacology	pharmacology	NOUN
iajs-2138	118	7	.	.	PUNCT
iajs-2138	119	1	2013	2013	NUM
iajs-2138	119	2	,	,	PUNCT
iajs-2138	119	3	5	5	NUM
iajs-2138	119	4	,	,	PUNCT
iajs-2138	119	5	1	1	NUM
iajs-2138	119	6	-	-	SYM
iajs-2138	119	7	9	9	NUM
iajs-2138	119	8	.	.	NOUN
iajs-2138	119	9	13	13	NUM
iajs-2138	119	10	.	.	PUNCT
iajs-2138	120	1	rosén	rosén	NOUN
iajs-2138	120	2	,	,	PUNCT
iajs-2138	120	3	c.	c.	NOUN
iajs-2138	120	4	;	;	PUNCT
iajs-2138	120	5	andersson	andersson	PROPN
iajs-2138	120	6	,	,	PUNCT
iajs-2138	120	7	c.h	c.h	PROPN
iajs-2138	120	8	.	.	PROPN
iajs-2138	120	9	;	;	PUNCT
iajs-2138	120	10	andreasson	andreasson	NOUN
iajs-2138	120	11	,	,	PUNCT
iajs-2138	120	12	u.	u.	PROPN
iajs-2138	120	13	;	;	PUNCT
iajs-2138	120	14	molinuevo	molinuevo	PROPN
iajs-2138	120	15	,	,	PUNCT
iajs-2138	120	16	j.l	j.l	PROPN
iajs-2138	120	17	.	.	PROPN
iajs-2138	120	18	;	;	PUNCT
iajs-2138	120	19	bjerke	bjerke	PROPN
iajs-2138	120	20	,	,	PUNCT
iajs-2138	120	21	m.	m.	NOUN
iajs-2138	120	22	;	;	PUNCT
iajs-2138	120	23	rami	rami	PROPN
iajs-2138	120	24	,	,	PUNCT
iajs-2138	120	25	l.	l.	PROPN
iajs-2138	120	26	;	;	PUNCT
iajs-2138	120	27	lladó	lladó	NOUN
iajs-2138	120	28	,	,	PUNCT
iajs-2138	120	29	a.	a.	NOUN
iajs-2138	120	30	;	;	PUNCT
iajs-2138	120	31	blennow	blennow	ADV
iajs-2138	120	32	,	,	PUNCT
iajs-2138	120	33	k.	k.	PROPN
iajs-2138	120	34	;	;	PUNCT
iajs-2138	120	35	zetterberg	zetterberg	PROPN
iajs-2138	120	36	,	,	PUNCT
iajs-2138	120	37	h.	h.	PROPN
iajs-2138	120	38	increased	increase	VERB
iajs-2138	120	39	levels	level	NOUN
iajs-2138	120	40	of	of	ADP
iajs-2138	120	41	chitotriosidase	chitotriosidase	NOUN
iajs-2138	120	42	and	and	CCONJ
iajs-2138	120	43	ykl-40	ykl-40	NOUN
iajs-2138	120	44	in	in	ADP
iajs-2138	120	45	cerebrospinal	cerebrospinal	ADJ
iajs-2138	120	46	fluid	fluid	NOUN
iajs-2138	120	47	from	from	ADP
iajs-2138	120	48	patients	patient	NOUN
iajs-2138	120	49	with	with	ADP
iajs-2138	120	50	alzheimer	alzheimer	PROPN
iajs-2138	120	51	’s	’s	PART
iajs-2138	120	52	disease	disease	NOUN
iajs-2138	120	53	.	.	PUNCT
iajs-2138	121	1	dementia	dementia	NOUN
iajs-2138	121	2	and	and	CCONJ
iajs-2138	121	3	geriatric	geriatric	ADJ
iajs-2138	121	4	cognitive	cognitive	ADJ
iajs-2138	121	5	disorders	disorder	NOUN
iajs-2138	121	6	extra	extra	ADJ
iajs-2138	121	7	.	.	PUNCT
iajs-2138	121	8	2014	2014	NUM
iajs-2138	121	9	,	,	PUNCT
iajs-2138	121	10	4	4	NUM
iajs-2138	121	11	,	,	PUNCT
iajs-2138	121	12	297–304	297–304	NUM
iajs-2138	121	13	.	.	PUNCT
iajs-2138	122	1	14	14	NUM
iajs-2138	122	2	.	.	PUNCT
iajs-2138	123	1	james	james	PROPN
iajs-2138	123	2	,	,	PUNCT
iajs-2138	123	3	a.	a.	NOUN
iajs-2138	123	4	;	;	PUNCT
iajs-2138	123	5	reinius	reinius	PROPN
iajs-2138	123	6	,	,	PUNCT
iajs-2138	123	7	l.	l.	PROPN
iajs-2138	123	8	;	;	PUNCT
iajs-2138	123	9	verhoek	verhoek	NOUN
iajs-2138	123	10	,	,	PUNCT
iajs-2138	123	11	m.	m.	NOUN
iajs-2138	123	12	the	the	DET
iajs-2138	123	13	chitinase	chitinase	NOUN
iajs-2138	123	14	proteins	protein	NOUN
iajs-2138	123	15	ykl-40	ykl-40	NOUN
iajs-2138	123	16	and	and	CCONJ
iajs-2138	123	17	chitotriosidase	chitotriosidase	NOUN
iajs-2138	123	18	are	be	AUX
iajs-2138	123	19	increased	increase	VERB
iajs-2138	123	20	in	in	ADP
iajs-2138	123	21	both	both	CCONJ
iajs-2138	123	22	asthma	asthma	NOUN
iajs-2138	123	23	and	and	CCONJ
iajs-2138	123	24	copd	copd	PROPN
iajs-2138	123	25	.	.	PUNCT
iajs-2138	124	1	american	american	ADJ
iajs-2138	124	2	journal	journal	PROPN
iajs-2138	124	3	of	of	ADP
iajs-2138	124	4	respiratory	respiratory	ADJ
iajs-2138	124	5	and	and	CCONJ
iajs-2138	124	6	critical	critical	ADJ
iajs-2138	124	7	care	care	NOUN
iajs-2138	124	8	medicine	medicine	NOUN
iajs-2138	124	9	.	.	PUNCT
iajs-2138	125	1	2015	2015	NUM
iajs-2138	125	2	,	,	PUNCT
iajs-2138	125	3	193	193	NUM
iajs-2138	125	4	,	,	PUNCT
iajs-2138	125	5	1	1	NUM
iajs-2138	125	6	-	-	SYM
iajs-2138	125	7	5	5	NUM
iajs-2138	125	8	.	.	NOUN
iajs-2138	125	9	15	15	NUM
iajs-2138	125	10	.	.	PUNCT
iajs-2138	126	1	trinder	trinder	NOUN
iajs-2138	126	2	,	,	PUNCT
iajs-2138	126	3	p.	p.	NOUN
iajs-2138	126	4	determination	determination	NOUN
iajs-2138	126	5	of	of	ADP
iajs-2138	126	6	blood	blood	NOUN
iajs-2138	126	7	glucose	glucose	NOUN
iajs-2138	126	8	using	use	VERB
iajs-2138	126	9	an	an	DET
iajs-2138	126	10	oxidaseperoxidase	oxidaseperoxidase	ADJ
iajs-2138	126	11	system	system	NOUN
iajs-2138	126	12	with	with	ADP
iajs-2138	126	13	a	a	DET
iajs-2138	126	14	non	non	ADJ
iajs-2138	126	15	-	-	ADJ
iajs-2138	126	16	carcinogenic	carcinogenic	ADJ
iajs-2138	126	17	chromogen	chromogen	NOUN
iajs-2138	126	18	.	.	PUNCT
iajs-2138	127	1	journal	journal	PROPN
iajs-2138	127	2	of	of	ADP
iajs-2138	127	3	clinical	clinical	ADJ
iajs-2138	127	4	pathology	pathology	NOUN
iajs-2138	127	5	.	.	PUNCT
iajs-2138	128	1	1969	1969	NUM
iajs-2138	128	2	,	,	PUNCT
iajs-2138	128	3	22	22	NUM
iajs-2138	128	4	,	,	PUNCT
iajs-2138	128	5	2427	2427	NUM
iajs-2138	128	6	.	.	PUNCT
iajs-2138	129	1	16	16	NUM
iajs-2138	129	2	.	.	X
iajs-2138	130	1	caryon	caryon	NOUN
iajs-2138	130	2	,	,	PUNCT
iajs-2138	130	3	p.	p.	NOUN
iajs-2138	130	4	;	;	PUNCT
iajs-2138	130	5	niccoli	niccoli	PROPN
iajs-2138	130	6	-	-	PUNCT
iajs-2138	130	7	sire	sire	NOUN
iajs-2138	130	8	,	,	PUNCT
iajs-2138	130	9	p.	p.	NOUN
iajs-2138	130	10	;	;	PUNCT
iajs-2138	130	11	lejeune	lejeune	PROPN
iajs-2138	130	12	,	,	PUNCT
iajs-2138	130	13	p.	p.	PROPN
iajs-2138	130	14	recommendation	recommendation	NOUN
iajs-2138	130	15	consensus	consensus	NOUN
iajs-2138	130	16	diagnostic	diagnostic	ADJ
iajs-2138	130	17	surveillance	surveillance	NOUN
iajs-2138	130	18	des	des	X
iajs-2138	130	19	maladies	maladie	VERB
iajs-2138	130	20	des	des	PROPN
iajs-2138	130	21	la	la	PROPN
iajs-2138	130	22	gland	gland	PROPN
iajs-2138	130	23	thyroid	thyroid	NOUN
iajs-2138	130	24	.	.	PUNCT
iajs-2138	131	1	annals	annal	NOUN
iajs-2138	131	2	of	of	ADP
iajs-2138	131	3	clinical	clinical	ADJ
iajs-2138	131	4	biology	biology	NOUN
iajs-2138	131	5	.	.	PUNCT
iajs-2138	132	1	2002	2002	NUM
iajs-2138	132	2	,	,	PUNCT
iajs-2138	132	3	60	60	NUM
iajs-2138	132	4	,	,	PUNCT
iajs-2138	132	5	27	27	NUM
iajs-2138	132	6	-	-	SYM
iajs-2138	132	7	32	32	NUM
iajs-2138	132	8	.	.	PUNCT
iajs-2138	133	1	https://www.ncbi.nlm.nih.gov/pubmed/?term=fleiner%20hf%5bauthor%5d&cauthor=true&cauthor_uid=26583583	https://www.ncbi.nlm.nih.gov/pubmed/?term=fleiner%20hf%5bauthor%5d&cauthor=true&cauthor_uid=26583583	PROPN
iajs-2138	133	2	https://www.ncbi.nlm.nih.gov/pubmed/?term=bj%c3%b8ro%20t%5bauthor%5d&cauthor=true&cauthor_uid=26583583	https://www.ncbi.nlm.nih.gov/pubmed/?term=bj%c3%b8ro%20t%5bauthor%5d&cauthor=true&cauthor_uid=26583583	PROPN
iajs-2138	134	1	https://www.ncbi.nlm.nih.gov/pubmed/?term=midthjell%20k%5bauthor%5d&cauthor=true&cauthor_uid=26583583	https://www.ncbi.nlm.nih.gov/pubmed/?term=midthjell%20k%5bauthor%5d&cauthor=true&cauthor_uid=26583583	PROPN
iajs-2138	134	2	https://www.ncbi.nlm.nih.gov/pubmed/?term=grill%20v%5bauthor%5d&cauthor=true&cauthor_uid=26583583	https://www.ncbi.nlm.nih.gov/pubmed/?term=grill%20v%5bauthor%5d&cauthor=true&cauthor_uid=26583583	VERB
iajs-2138	134	3	https://www.ncbi.nlm.nih.gov/pubmed/?term=%c3%85svold%20bo%5bauthor%5d&cauthor=true&cauthor_uid=26583583	https://www.ncbi.nlm.nih.gov/pubmed/?term=%c3%85svold%20bo%5bauthor%5d&cauthor=true&cauthor_uid=26583583	NOUN
iajs-2138	134	4	https://www.ncbi.nlm.nih.gov/pubmed/26583583	https://www.ncbi.nlm.nih.gov/pubmed/26583583	ADP
iajs-2138	134	5	https://www.ncbi.nlm.nih.gov/pubmed/?term=van%20aalten%20dm%5bauthor%5d&cauthor=true&cauthor_uid=10823940	https://www.ncbi.nlm.nih.gov/pubmed/?term=van%20aalten%20dm%5bauthor%5d&cauthor=true&cauthor_uid=10823940	NOUN
iajs-2138	134	6	https://www.ncbi.nlm.nih.gov/pubmed/?term=synstad%20b%5bauthor%5d&cauthor=true&cauthor_uid=10823940	https://www.ncbi.nlm.nih.gov/pubmed/?term=synstad%20b%5bauthor%5d&cauthor=true&cauthor_uid=10823940	NOUN
iajs-2138	134	7	https://www.ncbi.nlm.nih.gov/pubmed/?term=brurberg%20mb%5bauthor%5d&cauthor=true&cauthor_uid=10823940	https://www.ncbi.nlm.nih.gov/pubmed/?term=brurberg%20mb%5bauthor%5d&cauthor=true&cauthor_uid=10823940	NOUN
iajs-2138	134	8	https://www.ncbi.nlm.nih.gov/pubmed/?term=hough%20e%5bauthor%5d&cauthor=true&cauthor_uid=10823940	https://www.ncbi.nlm.nih.gov/pubmed/?term=hough%20e%5bauthor%5d&cauthor=true&cauthor_uid=10823940	NOUN
iajs-2138	134	9	https://www.ncbi.nlm.nih.gov/pubmed/?term=riise%20bw%5bauthor%5d&cauthor=true&cauthor_uid=10823940	https://www.ncbi.nlm.nih.gov/pubmed/?term=riise%20bw%5bauthor%5d&cauthor=true&cauthor_uid=10823940	NOUN
iajs-2138	134	10	https://www.ncbi.nlm.nih.gov/pubmed/?term=eijsink%20vg%5bauthor%5d&cauthor=true&cauthor_uid=10823940	https://www.ncbi.nlm.nih.gov/pubmed/?term=eijsink%20vg%5bauthor%5d&cauthor=true&cauthor_uid=10823940	PROPN
iajs-2138	134	11	https://www.ncbi.nlm.nih.gov/pubmed/?term=eijsink%20vg%5bauthor%5d&cauthor=true&cauthor_uid=10823940	https://www.ncbi.nlm.nih.gov/pubmed/?term=eijsink%20vg%5bauthor%5d&cauthor=true&cauthor_uid=10823940	PROPN
iajs-2138	134	12	https://www.ncbi.nlm.nih.gov/pubmed/?term=wierenga%20rk%5bauthor%5d&cauthor=true&cauthor_uid=10823940	https://www.ncbi.nlm.nih.gov/pubmed/?term=wierenga%20rk%5bauthor%5d&cauthor=true&cauthor_uid=10823940	NOUN
iajs-2138	134	13	https://www.ncbi.nlm.nih.gov/pubmed/?term=stockinger%20lw%5bauthor%5d&cauthor=true&cauthor_uid=26116146	https://www.ncbi.nlm.nih.gov/pubmed/?term=stockinger%20lw%5bauthor%5d&cauthor=true&cauthor_uid=26116146	PROPN
iajs-2138	134	14	https://www.ncbi.nlm.nih.gov/pubmed/?term=eide%20kb%5bauthor%5d&cauthor=true&cauthor_uid=26116146	https://www.ncbi.nlm.nih.gov/pubmed/?term=eide%20kb%5bauthor%5d&cauthor=true&cauthor_uid=26116146	PROPN
iajs-2138	134	15	https://www.ncbi.nlm.nih.gov/pubmed/?term=dybvik%20ai%5bauthor%5d&cauthor=true&cauthor_uid=26116146	https://www.ncbi.nlm.nih.gov/pubmed/?term=dybvik%20ai%5bauthor%5d&cauthor=true&cauthor_uid=26116146	PROPN
iajs-2138	134	16	https://www.ncbi.nlm.nih.gov/pubmed/?term=sletta%20h%5bauthor%5d&cauthor=true&cauthor_uid=26116146	https://www.ncbi.nlm.nih.gov/pubmed/?term=sletta%20h%5bauthor%5d&cauthor=true&cauthor_uid=26116146	PROPN
iajs-2138	134	17	https://www.ncbi.nlm.nih.gov/pubmed/?term=v%c3%a5rum%20km%5bauthor%5d&cauthor=true&cauthor_uid=26116146	https://www.ncbi.nlm.nih.gov/pubmed/?term=v%c3%a5rum%20km%5bauthor%5d&cauthor=true&cauthor_uid=26116146	NOUN
iajs-2138	134	18	https://www.ncbi.nlm.nih.gov/pubmed/?term=eijsink%20vg%5bauthor%5d&cauthor=true&cauthor_uid=26116146	https://www.ncbi.nlm.nih.gov/pubmed/?term=eijsink%20vg%5bauthor%5d&cauthor=true&cauthor_uid=26116146	PROPN
iajs-2138	134	19	https://www.ncbi.nlm.nih.gov/pubmed/?term=eijsink%20vg%5bauthor%5d&cauthor=true&cauthor_uid=26116146	https://www.ncbi.nlm.nih.gov/pubmed/?term=eijsink%20vg%5bauthor%5d&cauthor=true&cauthor_uid=26116146	PROPN
iajs-2138	134	20	https://www.ncbi.nlm.nih.gov/pubmed/?term=t%c3%b8ndervik%20a%5bauthor%5d&cauthor=true&cauthor_uid=26116146	https://www.ncbi.nlm.nih.gov/pubmed/?term=t%c3%b8ndervik%20a%5bauthor%5d&cauthor=true&cauthor_uid=26116146	PROPN
iajs-2138	134	21	https://www.ncbi.nlm.nih.gov/pubmed/?term=s%c3%b8rlie%20m%5bauthor%5d&cauthor=true&cauthor_uid=26116146	https://www.ncbi.nlm.nih.gov/pubmed/?term=s%c3%b8rlie%20m%5bauthor%5d&cauthor=true&cauthor_uid=26116146	PROPN
iajs-2138	134	22	https://www.ncbi.nlm.nih.gov/pubmed/?term=ros%c3%a9n%20c%5bauthor%5d&cauthor=true&cauthor_uid=25254036	https://www.ncbi.nlm.nih.gov/pubmed/?term=ros%c3%a9n%20c%5bauthor%5d&cauthor=true&cauthor_uid=25254036	PROPN
iajs-2138	134	23	https://www.ncbi.nlm.nih.gov/pubmed/?term=andersson%20ch%5bauthor%5d&cauthor=true&cauthor_uid=25254036	https://www.ncbi.nlm.nih.gov/pubmed/?term=andersson%20ch%5bauthor%5d&cauthor=true&cauthor_uid=25254036	PROPN
iajs-2138	134	24	https://www.ncbi.nlm.nih.gov/pubmed/?term=andreasson%20u%5bauthor%5d&cauthor=true&cauthor_uid=25254036	https://www.ncbi.nlm.nih.gov/pubmed/?term=andreasson%20u%5bauthor%5d&cauthor=true&cauthor_uid=25254036	PROPN
iajs-2138	134	25	https://www.ncbi.nlm.nih.gov/pubmed/?term=molinuevo%20jl%5bauthor%5d&cauthor=true&cauthor_uid=25254036	https://www.ncbi.nlm.nih.gov/pubmed/?term=molinuevo%20jl%5bauthor%5d&cauthor=true&cauthor_uid=25254036	PROPN
iajs-2138	134	26	https://www.ncbi.nlm.nih.gov/pubmed/?term=bjerke%20m%5bauthor%5d&cauthor=true&cauthor_uid=25254036	https://www.ncbi.nlm.nih.gov/pubmed/?term=bjerke%20m%5bauthor%5d&cauthor=true&cauthor_uid=25254036	PROPN
iajs-2138	134	27	https://www.ncbi.nlm.nih.gov/pubmed/?term=rami%20l%5bauthor%5d&cauthor=true&cauthor_uid=25254036	https://www.ncbi.nlm.nih.gov/pubmed/?term=rami%20l%5bauthor%5d&cauthor=true&cauthor_uid=25254036	X
iajs-2138	134	28	https://www.ncbi.nlm.nih.gov/pubmed/?term=rami%20l%5bauthor%5d&cauthor=true&cauthor_uid=25254036	https://www.ncbi.nlm.nih.gov/pubmed/?term=rami%20l%5bauthor%5d&cauthor=true&cauthor_uid=25254036	PROPN
iajs-2138	134	29	https://www.ncbi.nlm.nih.gov/pubmed/?term=llad%c3%b3%20a%5bauthor%5d&cauthor=true&cauthor_uid=25254036	https://www.ncbi.nlm.nih.gov/pubmed/?term=llad%c3%b3%20a%5bauthor%5d&cauthor=true&cauthor_uid=25254036	NOUN
iajs-2138	134	30	https://www.ncbi.nlm.nih.gov/pubmed/?term=blennow%20k%5bauthor%5d&cauthor=true&cauthor_uid=25254036	https://www.ncbi.nlm.nih.gov/pubmed/?term=blennow%20k%5bauthor%5d&cauthor=true&cauthor_uid=25254036	PROPN
iajs-2138	134	31	https://www.ncbi.nlm.nih.gov/pubmed/?term=zetterberg%20h%5bauthor%5d&cauthor=true&cauthor_uid=25254036	https://www.ncbi.nlm.nih.gov/pubmed/?term=zetterberg%20h%5bauthor%5d&cauthor=true&cauthor_uid=25254036	NOUN
iajs-2138	134	32	45	45	NUM
iajs-2138	134	33	ibn	ibn	PROPN
iajs-2138	134	34	al	al	PROPN
iajs-2138	134	35	-	-	PUNCT
iajs-2138	134	36	haitham	haitham	PROPN
iajs-2138	134	37	jour	jour	X
iajs-2138	134	38	.	.	PROPN
iajs-2138	135	1	for	for	ADP
iajs-2138	135	2	pure	pure	ADJ
iajs-2138	135	3	&	&	CCONJ
iajs-2138	135	4	appl	appl	PROPN
iajs-2138	135	5	.	.	PUNCT
iajs-2138	136	1	sci	sci	PROPN
iajs-2138	136	2	.	.	PROPN
iajs-2138	136	3	32	32	NUM
iajs-2138	136	4	(	(	PUNCT
iajs-2138	136	5	2	2	NUM
iajs-2138	136	6	)	)	PUNCT
iajs-2138	136	7	2019	2019	NUM
iajs-2138	136	8	17	17	NUM
iajs-2138	136	9	.	.	PUNCT
iajs-2138	137	1	shivanada	shivanada	PROPN
iajs-2138	137	2	,	,	PUNCT
iajs-2138	137	3	n.	n.	PROPN
iajs-2138	137	4	manipal	manipal	PROPN
iajs-2138	137	5	manual	manual	NOUN
iajs-2138	137	6	of	of	ADP
iajs-2138	137	7	clinical	clinical	ADJ
iajs-2138	137	8	biochemistry	biochemistry	NOUN
iajs-2138	137	9	3	3	NUM
iajs-2138	137	10	rd	rd	NOUN
iajs-2138	137	11	edition	edition	NOUN
iajs-2138	137	12	.	.	PUNCT
iajs-2138	138	1	medical	medical	ADJ
iajs-2138	138	2	publishers	publisher	NOUN
iajs-2138	138	3	(	(	PUNCT
iajs-2138	138	4	p	p	NOUN
iajs-2138	138	5	)	)	PUNCT
iajs-2138	138	6	ltd	ltd	PROPN
iajs-2138	138	7	.	.	PROPN
iajs-2138	138	8	2007	2007	NUM
iajs-2138	138	9	.	.	PUNCT
iajs-2138	139	1	18	18	NUM
iajs-2138	139	2	.	.	X
iajs-2138	140	1	elmenshawi	elmenshawi	PROPN
iajs-2138	140	2	,	,	PUNCT
iajs-2138	140	3	i.	i.	PROPN
iajs-2138	140	4	;	;	PUNCT
iajs-2138	140	5	alotaibi	alotaibi	PROPN
iajs-2138	140	6	,	,	PUNCT
iajs-2138	140	7	s.	s.	PROPN
iajs-2138	140	8	;	;	PUNCT
iajs-2138	140	9	alazmi	alazmi	ADV
iajs-2138	140	10	,	,	PUNCT
iajs-2138	140	11	a.	a.	NOUN
iajs-2138	140	12	;	;	PUNCT
iajs-2138	140	13	alazmi	alazmi	ADV
iajs-2138	140	14	,	,	PUNCT
iajs-2138	140	15	a.	a.	NOUN
iajs-2138	140	16	;	;	PUNCT
iajs-2138	140	17	alruwaili	alruwaili	NOUN
iajs-2138	140	18	,	,	PUNCT
iajs-2138	140	19	f.	f.	PROPN
iajs-2138	140	20	;	;	PUNCT
iajs-2138	140	21	alazmi	alazmi	ADV
iajs-2138	140	22	,	,	PUNCT
iajs-2138	140	23	n.	n.	NOUN
iajs-2138	140	24	;	;	PUNCT
iajs-2138	140	25	alazmi	alazmi	ADV
iajs-2138	140	26	,	,	PUNCT
iajs-2138	140	27	z.	z.	PROPN
iajs-2138	140	28	prevalence	prevalence	NOUN
iajs-2138	140	29	of	of	ADP
iajs-2138	140	30	thyroid	thyroid	NOUN
iajs-2138	140	31	dysfunction	dysfunction	NOUN
iajs-2138	140	32	in	in	ADP
iajs-2138	140	33	diabetic	diabetic	ADJ
iajs-2138	140	34	patients	patient	NOUN
iajs-2138	140	35	,	,	PUNCT
iajs-2138	140	36	journal	journal	NOUN
iajs-2138	140	37	of	of	ADP
iajs-2138	140	38	diabetes	diabetes	NOUN
iajs-2138	140	39	metabolic	metabolic	NOUN
iajs-2138	140	40	disorders	disorder	NOUN
iajs-2138	140	41	&	&	CCONJ
iajs-2138	140	42	control	control	NOUN
iajs-2138	140	43	.	.	PUNCT
iajs-2138	141	1	2017	2017	NUM
iajs-2138	141	2	,	,	PUNCT
iajs-2138	141	3	4	4	NUM
iajs-2138	141	4	,	,	PUNCT
iajs-2138	141	5	55	55	NUM
iajs-2138	141	6	-	-	SYM
iajs-2138	141	7	56	56	NUM
iajs-2138	141	8	.	.	NOUN
iajs-2138	142	1	19	19	NUM
iajs-2138	142	2	.	.	X
iajs-2138	142	3	jain	jain	PROPN
iajs-2138	142	4	,	,	PUNCT
iajs-2138	142	5	g.	g.	PROPN
iajs-2138	142	6	;	;	PUNCT
iajs-2138	142	7	marwaha	marwaha	PROPN
iajs-2138	142	8	,	,	PUNCT
iajs-2138	142	9	t.s	t.s	PROPN
iajs-2138	142	10	.	.	PROPN
iajs-2138	142	11	;	;	PUNCT
iajs-2138	142	12	khurana	khurana	PROPN
iajs-2138	142	13	,	,	PUNCT
iajs-2138	142	14	a.	a.	NOUN
iajs-2138	142	15	;	;	PUNCT
iajs-2138	142	16	dhoat	dhoat	PROPN
iajs-2138	142	17	,	,	PUNCT
iajs-2138	142	18	p.s	p.s	PROPN
iajs-2138	142	19	.	.	PROPN
iajs-2138	142	20	prevalence	prevalence	NOUN
iajs-2138	142	21	of	of	ADP
iajs-2138	142	22	thyroid	thyroid	NOUN
iajs-2138	142	23	disorders	disorder	NOUN
iajs-2138	142	24	in	in	ADP
iajs-2138	142	25	patients	patient	NOUN
iajs-2138	142	26	of	of	ADP
iajs-2138	142	27	type	type	NOUN
iajs-2138	142	28	2	2	NUM
iajs-2138	142	29	diabetes	diabetes	NOUN
iajs-2138	142	30	mellitus	mellitus	NOUN
iajs-2138	142	31	.	.	PUNCT
iajs-2138	143	1	international	international	ADJ
iajs-2138	143	2	journal	journal	PROPN
iajs-2138	143	3	of	of	ADP
iajs-2138	143	4	research	research	NOUN
iajs-2138	143	5	in	in	ADP
iajs-2138	143	6	medical	medical	ADJ
iajs-2138	143	7	sciences	science	NOUN
iajs-2138	143	8	.	.	PUNCT
iajs-2138	144	1	2013	2013	NUM
iajs-2138	144	2	,	,	PUNCT
iajs-2138	144	3	2	2	NUM
iajs-2138	144	4	,	,	PUNCT
iajs-2138	144	5	75	75	NUM
iajs-2138	144	6	-	-	SYM
iajs-2138	144	7	78	78	NUM
iajs-2138	144	8	.	.	PUNCT
iajs-2138	145	1	20	20	NUM
iajs-2138	145	2	.	.	PUNCT
iajs-2138	146	1	nicholas	nicholas	PROPN
iajs-2138	146	2	,	,	PUNCT
iajs-2138	146	3	a.	a.	NOUN
iajs-2138	146	4	type	type	NOUN
iajs-2138	146	5	2	2	NUM
iajs-2138	146	6	diabetes	diabetes	NOUN
iajs-2138	146	7	mellitus	mellitus	NOUN
iajs-2138	146	8	and	and	CCONJ
iajs-2138	146	9	thyroid	thyroid	VERB
iajs-2138	146	10	dysfunction	dysfunction	NOUN
iajs-2138	146	11	:	:	PUNCT
iajs-2138	146	12	an	an	DET
iajs-2138	146	13	intertwined	intertwine	VERB
iajs-2138	146	14	duo	duo	NOUN
iajs-2138	146	15	.	.	PUNCT
iajs-2138	147	1	african	african	ADJ
iajs-2138	147	2	journal	journal	PROPN
iajs-2138	147	3	of	of	ADP
iajs-2138	147	4	diabetes	diabetes	NOUN
iajs-2138	147	5	medicine	medicine	NOUN
iajs-2138	147	6	.	.	PUNCT
iajs-2138	148	1	2015	2015	NUM
iajs-2138	148	2	,	,	PUNCT
iajs-2138	148	3	22	22	NUM
iajs-2138	148	4	,	,	PUNCT
iajs-2138	148	5	5	5	NUM
iajs-2138	148	6	-	-	SYM
iajs-2138	148	7	7	7	NUM
iajs-2138	148	8	.	.	NUM
iajs-2138	148	9	21	21	NUM
iajs-2138	148	10	.	.	PUNCT
iajs-2138	149	1	raghuwanshi	raghuwanshi	PROPN
iajs-2138	149	2	,	,	PUNCT
iajs-2138	149	3	p.k	p.k	PROPN
iajs-2138	149	4	.	.	PROPN
iajs-2138	149	5	;	;	PUNCT
iajs-2138	149	6	singh	singh	PROPN
iajs-2138	149	7	rajput	rajput	PROPN
iajs-2138	149	8	,	,	PUNCT
iajs-2138	149	9	d.p	d.p	PROPN
iajs-2138	149	10	.	.	PROPN
iajs-2138	149	11	;	;	PUNCT
iajs-2138	149	12	ratere	ratere	PROPN
iajs-2138	149	13	,	,	PUNCT
iajs-2138	149	14	b.k	b.k	PROPN
iajs-2138	149	15	.	.	PROPN
iajs-2138	149	16	;	;	PUNCT
iajs-2138	149	17	jain	jain	PROPN
iajs-2138	149	18	,	,	PUNCT
iajs-2138	149	19	r.	r.	PROPN
iajs-2138	149	20	;	;	PUNCT
iajs-2138	149	21	patel	patel	PROPN
iajs-2138	149	22	,	,	PUNCT
iajs-2138	149	23	n.	n.	PROPN
iajs-2138	149	24	;	;	PUNCT
iajs-2138	149	25	jian	jian	PROPN
iajs-2138	149	26	,	,	PUNCT
iajs-2138	149	27	s.	s.	PROPN
iajs-2138	149	28	evaluation	evaluation	NOUN
iajs-2138	149	29	of	of	ADP
iajs-2138	149	30	thyroid	thyroid	NOUN
iajs-2138	149	31	dysfunction	dysfunction	NOUN
iajs-2138	149	32	among	among	ADP
iajs-2138	149	33	type	type	NOUN
iajs-2138	149	34	2	2	NUM
iajs-2138	149	35	diabetic	diabetic	ADJ
iajs-2138	149	36	patients	patient	NOUN
iajs-2138	149	37	.	.	PUNCT
iajs-2138	150	1	asian	asian	ADJ
iajs-2138	150	2	journal	journal	PROPN
iajs-2138	150	3	of	of	ADP
iajs-2138	150	4	medical	medical	ADJ
iajs-2138	150	5	science	science	NOUN
iajs-2138	150	6	.	.	PUNCT
iajs-2138	151	1	2015	2015	NUM
iajs-2138	151	2	,	,	PUNCT
iajs-2138	151	3	6	6	NUM
iajs-2138	151	4	,	,	PUNCT
iajs-2138	151	5	33	33	NUM
iajs-2138	151	6	-	-	SYM
iajs-2138	151	7	37	37	NUM
iajs-2138	151	8	.	.	PUNCT
iajs-2138	152	1	22	22	NUM
iajs-2138	152	2	.	.	X
iajs-2138	152	3	sonmez	sonmez	NOUN
iajs-2138	152	4	,	,	PUNCT
iajs-2138	152	5	a.	a.	NOUN
iajs-2138	152	6	;	;	PUNCT
iajs-2138	152	7	haymana	haymana	PROPN
iajs-2138	152	8	,	,	PUNCT
iajs-2138	152	9	c.	c.	PROPN
iajs-2138	152	10	;	;	PUNCT
iajs-2138	152	11	tapan	tapan	NOUN
iajs-2138	152	12	,	,	PUNCT
iajs-2138	152	13	s.	s.	PROPN
iajs-2138	152	14	;	;	PUNCT
iajs-2138	152	15	safer	safe	ADJ
iajs-2138	152	16	,	,	PUNCT
iajs-2138	152	17	u.	u.	NOUN
iajs-2138	152	18	;	;	PUNCT
iajs-2138	152	19	celebi	celebi	NOUN
iajs-2138	152	20	,	,	PUNCT
iajs-2138	152	21	g.	g.	PROPN
iajs-2138	152	22	;	;	PUNCT
iajs-2138	152	23	ozturk	ozturk	PROPN
iajs-2138	152	24	,	,	PUNCT
iajs-2138	152	25	o.	o.	PROPN
iajs-2138	152	26	;	;	PUNCT
iajs-2138	152	27	genc	genc	PROPN
iajs-2138	152	28	,	,	PUNCT
iajs-2138	152	29	h.	h.	PROPN
iajs-2138	152	30	;	;	PUNCT
iajs-2138	152	31	dogru	dogru	PROPN
iajs-2138	152	32	,	,	PUNCT
iajs-2138	152	33	t.	t.	PROPN
iajs-2138	152	34	;	;	PUNCT
iajs-2138	152	35	tasci	tasci	PROPN
iajs-2138	152	36	,	,	PUNCT
iajs-2138	152	37	i.	i.	NOUN
iajs-2138	152	38	;	;	PUNCT
iajs-2138	152	39	erdem	erdem	PROPN
iajs-2138	152	40	,	,	PUNCT
iajs-2138	152	41	g.	g.	PROPN
iajs-2138	152	42	;	;	PUNCT
iajs-2138	152	43	taslipinar	taslipinar	PROPN
iajs-2138	152	44	,	,	PUNCT
iajs-2138	152	45	a.	a.	NOUN
iajs-2138	152	46	;	;	PUNCT
iajs-2138	152	47	aydogdu	aydogdu	ADV
iajs-2138	152	48	,	,	PUNCT
iajs-2138	152	49	a.	a.	NOUN
iajs-2138	152	50	;	;	PUNCT
iajs-2138	152	51	yilmaz	yilmaz	PROPN
iajs-2138	152	52	,	,	PUNCT
iajs-2138	152	53	mi	mi	PROPN
iajs-2138	152	54	.	.	PROPN
iajs-2138	152	55	;	;	PUNCT
iajs-2138	153	1	kurt	kurt	PROPN
iajs-2138	153	2	,	,	PUNCT
iajs-2138	153	3	i.	i.	PROPN
iajs-2138	153	4	;	;	PUNCT
iajs-2138	153	5	kutlu	kutlu	PROPN
iajs-2138	153	6	,	,	PUNCT
iajs-2138	153	7	m.	m.	NOUN
iajs-2138	153	8	chitotriosidase	chitotriosidase	NOUN
iajs-2138	153	9	activity	activity	NOUN
iajs-2138	153	10	predicts	predict	VERB
iajs-2138	153	11	endothelial	endothelial	ADJ
iajs-2138	153	12	dysfunction	dysfunction	NOUN
iajs-2138	153	13	in	in	ADP
iajs-2138	153	14	type-2	type-2	NUM
iajs-2138	153	15	diabetes	diabetes	NOUN
iajs-2138	153	16	mellitus	mellitus	NOUN
iajs-2138	153	17	,	,	PUNCT
iajs-2138	153	18	endocrine	endocrine	PROPN
iajs-2138	153	19	.	.	PUNCT
iajs-2138	154	1	2010	2010	NUM
iajs-2138	154	2	,	,	PUNCT
iajs-2138	154	3	37	37	NUM
iajs-2138	154	4	,	,	PUNCT
iajs-2138	154	5	455	455	NUM
iajs-2138	154	6	-	-	SYM
iajs-2138	154	7	459	459	NUM
iajs-2138	154	8	.	.	PUNCT
iajs-2138	155	1	https://www.ncbi.nlm.nih.gov/pubmed/?term=sonmez%20a%5bauthor%5d&cauthor=true&cauthor_uid=20960168	https://www.ncbi.nlm.nih.gov/pubmed/?term=sonmez%20a%5bauthor%5d&cauthor=true&cauthor_uid=20960168	NOUN
iajs-2138	155	2	https://www.ncbi.nlm.nih.gov/pubmed/?term=haymana%20c%5bauthor%5d&cauthor=true&cauthor_uid=20960168	https://www.ncbi.nlm.nih.gov/pubmed/?term=haymana%20c%5bauthor%5d&cauthor=true&cauthor_uid=20960168	PROPN
iajs-2138	155	3	https://www.ncbi.nlm.nih.gov/pubmed/?term=tapan%20s%5bauthor%5d&cauthor=true&cauthor_uid=20960168	https://www.ncbi.nlm.nih.gov/pubmed/?term=tapan%20s%5bauthor%5d&cauthor=true&cauthor_uid=20960168	NUM
iajs-2138	155	4	https://www.ncbi.nlm.nih.gov/pubmed/?term=safer%20u%5bauthor%5d&cauthor=true&cauthor_uid=20960168	https://www.ncbi.nlm.nih.gov/pubmed/?term=safer%20u%5bauthor%5d&cauthor=true&cauthor_uid=20960168	NOUN
iajs-2138	155	5	https://www.ncbi.nlm.nih.gov/pubmed/?term=celebi%20g%5bauthor%5d&cauthor=true&cauthor_uid=20960168	https://www.ncbi.nlm.nih.gov/pubmed/?term=celebi%20g%5bauthor%5d&cauthor=true&cauthor_uid=20960168	PROPN
iajs-2138	155	6	https://www.ncbi.nlm.nih.gov/pubmed/?term=ozturk%20o%5bauthor%5d&cauthor=true&cauthor_uid=20960168	https://www.ncbi.nlm.nih.gov/pubmed/?term=ozturk%20o%5bauthor%5d&cauthor=true&cauthor_uid=20960168	NOUN
iajs-2138	155	7	https://www.ncbi.nlm.nih.gov/pubmed/?term=genc%20h%5bauthor%5d&cauthor=true&cauthor_uid=20960168	https://www.ncbi.nlm.nih.gov/pubmed/?term=genc%20h%5bauthor%5d&cauthor=true&cauthor_uid=20960168	NUM
iajs-2138	155	8	https://www.ncbi.nlm.nih.gov/pubmed/?term=genc%20h%5bauthor%5d&cauthor=true&cauthor_uid=20960168	https://www.ncbi.nlm.nih.gov/pubmed/?term=genc%20h%5bauthor%5d&cauthor=true&cauthor_uid=20960168	NUM
iajs-2138	155	9	https://www.ncbi.nlm.nih.gov/pubmed/?term=dogru%20t%5bauthor%5d&cauthor=true&cauthor_uid=20960168	https://www.ncbi.nlm.nih.gov/pubmed/?term=dogru%20t%5bauthor%5d&cauthor=true&cauthor_uid=20960168	NUM
iajs-2138	155	10	https://www.ncbi.nlm.nih.gov/pubmed/?term=tasci%20i%5bauthor%5d&cauthor=true&cauthor_uid=20960168	https://www.ncbi.nlm.nih.gov/pubmed/?term=tasci%20i%5bauthor%5d&cauthor=true&cauthor_uid=20960168	PROPN
iajs-2138	155	11	https://www.ncbi.nlm.nih.gov/pubmed/?term=erdem%20g%5bauthor%5d&cauthor=true&cauthor_uid=20960168	https://www.ncbi.nlm.nih.gov/pubmed/?term=erdem%20g%5bauthor%5d&cauthor=true&cauthor_uid=20960168	X
iajs-2138	155	12	https://www.ncbi.nlm.nih.gov/pubmed/?term=taslipinar%20a%5bauthor%5d&cauthor=true&cauthor_uid=20960168	https://www.ncbi.nlm.nih.gov/pubmed/?term=taslipinar%20a%5bauthor%5d&cauthor=true&cauthor_uid=20960168	NOUN
iajs-2138	155	13	https://www.ncbi.nlm.nih.gov/pubmed/?term=aydogdu%20a%5bauthor%5d&cauthor=true&cauthor_uid=20960168	https://www.ncbi.nlm.nih.gov/pubmed/?term=aydogdu%20a%5bauthor%5d&cauthor=true&cauthor_uid=20960168	PUNCT
iajs-2138	155	14	https://www.ncbi.nlm.nih.gov/pubmed/?term=yilmaz%20mi%5bauthor%5d&cauthor=true&cauthor_uid=20960168	https://www.ncbi.nlm.nih.gov/pubmed/?term=yilmaz%20mi%5bauthor%5d&cauthor=true&cauthor_uid=20960168	NOUN
iajs-2138	155	15	https://www.ncbi.nlm.nih.gov/pubmed/?term=kurt%20i%5bauthor%5d&cauthor=true&cauthor_uid=20960168	https://www.ncbi.nlm.nih.gov/pubmed/?term=kurt%20i%5bauthor%5d&cauthor=true&cauthor_uid=20960168	NOUN
iajs-2138	155	16	https://www.ncbi.nlm.nih.gov/pubmed/?term=kurt%20i%5bauthor%5d&cauthor=true&cauthor_uid=20960168	https://www.ncbi.nlm.nih.gov/pubmed/?term=kurt%20i%5bauthor%5d&cauthor=true&cauthor_uid=20960168	NOUN
iajs-2138	155	17	https://www.ncbi.nlm.nih.gov/pubmed/?term=kutlu%20m%5bauthor%5d&cauthor=true&cauthor_uid=20960168	https://www.ncbi.nlm.nih.gov/pubmed/?term=kutlu%20m%5bauthor%5d&cauthor=true&cauthor_uid=20960168	NOUN
iajs-2138	155	18	https://www.ncbi.nlm.nih.gov/pubmed/20960168	https://www.ncbi.nlm.nih.gov/pubmed/20960168	NUM